Podcasts about Laboratory

Join Ivoclar (AND US!) this February at LMT Lab Day in Chicago. Ivoclar will be offering 16 different educational lectures over the three-day event, giving dental professionals plenty of opportunities to learn, connect, and grow. Visit labday.com/Ivoclar to view the full schedule and register, and be sure to stop by and see the Ivoclar team in the Windy City. Cal-Lab Association Meeting in Chicago Feb 19-20 https://cal-lab.org/ LMT Lab Day Chicago Feb 19-21 https://lmtmag.com/lmtlabday Almost three years after his last appearance, Rob Nazzal returns to Voices From the Bench, this time joined by Mike Alessio of Bonadent Dental Laboratory (https://bonadent.com/). The conversation dives deep into lab leadership, culture, transparency, and how data—when used the right way—can empower teams instead of policing them. Mike shares his 32-year journey with Bonadent, from starting as a pickup-and-delivery driver to leading the Danaren division, and explains how a family-owned lab has grown into a multi-location organization without losing its people-first culture. Rob and Mike unpack the realities of tracking productivity on the lab floor, the challenges of sharing metrics openly, and why transparency builds trust, alignment, and accountability when done with intention. The discussion shifts to quality vs. productivity, the difficulty of truly measuring “quality,” and why labs must lead with craftsmanship before numbers. They also explore how digital workflows, QC processes, and proactive communication with doctors impact remakes, efficiency, and relationships. On the sales side, Rob breaks down how icortica (https://www.icortica.com/voices) helps labs grow by focusing on existing customers, improving retention, and giving sales teams real-time insights into what conversations they should be having—right before they walk into an office. Mike and Elvis share firsthand experiences using icortica (https://www.icortica.com/voices), highlighting how real-time data, centralized notes, and smart alerts change the way sales reps prepare, prioritize, and perform. The episode wraps with a look at Bonadent's unique culture (including their famous converted Walmart lab), long employee tenure, and why investing in people, transparency, and the right technology is the real key to sustainable growth in today's dental lab landscape. If you want to grow your business, you need clear insight into what's happening inside your operation and across your customer journey. That's where Icortica comes in. At Canadian Dental Labs, Icortica has become a cornerstone of how we operate—giving us at-a-glance visibility into performance, helping us focus our efforts, spot opportunities early, and solve problems before they grow. It takes the guesswork out of decision-making and shows us what to do next. Plus, the Icortica team is incredibly responsive and feels like a true partner in our success. If you're serious about growing your business and understanding your customers better, Icortica can get you there. Learn more at icortica.com/voices — Icortica, helping dental labs grow. Special Guests: Mike Alessio and Rob Nazzal.

We are often told exercise is good for boosting your mood, but a new Cochrane review has looked at what the evidence says about how much difference exercise can really make when treating depression.Many patients with chronic conditions fail to take medications as prescribed. We discuss a novel pill casing that can send a signal once it has been broken down in the stomach. Prof Giovanni Traverso, gastroenterologist and director of the Laboratory for Translational Engineering at MIT, explains how it works.A year on from the USAID freeze, global health journalist Andrew Green unpicks America's radically different influence on world health today. In Malawi's townships, many families can no longer afford charcoal or gas. Instead, they turn to burning plastic waste as cooking fuel. This keeps food on the table but fills kitchens and markets with toxic smoke, contributing to respiratory illness, pregnancy complications, and environmental damage. We hear from our reporter, Carrim Mpaweni.And we look at auto-brewery syndrome as researchers search for why some people's gut microbes produce high alcohol levels.Presenter: Claudia Hammond Producer: Hannah Robins Assistant producers: Jonathan Blackwell and Anna Charalambou

Butyrate is a short-chain fatty acid (SCFA) produced when gut bacteria ferment dietary fiber. It provides energy for colon cells and offers health benefits beyond basic nutrition Research suggests butyrate helps manage inflammatory bowel disease (IBD) by reducing inflammation, improving symptoms and strengthening gut barrier integrity Laboratory studies show butyrate helps inhibit cancer cell growth and trigger cell death in colorectal cancer cells, with clinical trials exploring its use alongside traditional treatments Butyrate has been shown to improve insulin sensitivity and glucose metabolism in metabolic disorders, while also influencing appetite-regulating hormones Studies show butyrate protects against neurodegenerative diseases by reducing brain inflammation and enhancing neuronal repair and survival

Join Ivoclar (AND US!) this February at LMT Lab Day in Chicago. Ivoclar will be offering 16 different educational lectures over the three-day event, giving dental professionals plenty of opportunities to learn, connect, and grow. Visit labday.com/Ivoclar to view the full schedule and register, and be sure to stop by and see the Ivoclar team in the Windy City. In this episode, Elvis and Barb sit down with Dr. Miles Cone, a prosthodontist whose path into dentistry is anything but traditional. From a childhood obsession with dinosaurs and living out of his Jeep, to serving in the Army and becoming a CDT, Dr. Cone shares how persistence, humility, and an appreciation for the lab side of dentistry shaped his career. Along the way, he opens up about failing the CDT exam, learning the true value of dental technicians, and why collaboration—not ego—is the key to better patient outcomes The conversation also dives deep into photography, storytelling, and seeing dentistry as both science and art. Dr. Cone explains how discovering dental photography transformed not only how he documents cases, but how he connects with patients and technicians alike. He and Barb and Elvis discuss raising your skills by putting your work out there, ignoring the trolls, and using critique to grow. The episode wraps with a preview of Dr. Cone's upcoming Ivoclar presentation at Lab Day Chicago (https://lmtmag.com/seminars/hiding-in-plain-sight-creating-fake-teeth-for-real-people-in-the-age-of-cosmetic-cliche), where he and technician Janelle will show how dentures and removables can be “hidden in plain sight” when done with intention, artistry, and respect for the entire dental team. A new year is the perfect time to reset, refocus, and set your dental business up for success. January isn't just about new goals—it's about working smarter with efficient, reliable systems that keep production running smoothly and predictably. Roland DGSHAPE milling solutions (https://www.rolanddga.com/products/dental/dwx-series) deliver the consistency and automation labs depend on to control costs, reduce remakes, and maximize every hour. With trusted Japanese engineering and mills like the DWX-53DC (https://www.rolanddga.com/products/dental/dwx-53dc-5-axis-dry-dental-milling-with-automatic-disc-changer) working even when you're not, you spend less time fixing problems and more time growing your business. Start the year strong with solutions built for productivity and profitability. That's the Roland DGSHAPE difference. Learn more at rolanddental.com Special Guest: Dr. Miles Cone.

Fluent Fiction - Italian: Braving the Waters: Uncovering Venezia's Secret Laboratory Find the full episode transcript, vocabulary words, and more:fluentfiction.com/it/episode/2026-01-07-23-34-02-it Story Transcript:It: Il freddo pungente dell'inverno avvolgeva Venezia.En: The biting cold of winter enveloped Venezia.It: Le calli erano silenziose, tranne quando il Vaporetto passava, lasciando onde leggere dietro di sé.En: The calli were silent, except when the Vaporetto passed by, leaving light waves behind it.It: Luca fissava il canale davanti a lui.En: Luca stared at the canal in front of him.It: Con Alessandra e Marco al suo fianco, il suo cuore batté forte nell'aria frizzante della città.En: With Alessandra and Marco by his side, his heart beat strongly in the crisp air of the city.It: "Luca, sei sicuro?"En: "Luca, are you sure?"It: chiese Alessandra, il suo cappotto stretto intorno a lei.En: asked Alessandra, her coat wrapped tightly around her.It: Voleva assicurarsi che fosse davvero pronto, non solo per il viaggio, ma anche per ciò che li aspettava al laboratorio segreto.En: She wanted to ensure he was truly ready, not just for the journey, but also for what awaited them at the secret laboratory.It: "Sì, devo farlo," rispose Luca, cercando di mascherare il tremito nella sua voce.En: "Yes, I have to do it," replied Luca, trying to mask the tremor in his voice.It: Il ricordo della sua passata esperienza in acqua lo tormentava, ma il desiderio di scoprire i segreti del laboratorio era più forte.En: The memory of his past experience in the water tormented him, but the desire to uncover the secrets of the laboratory was stronger.It: Il Vaporetto arrivò lentamente, e Luca salì con un respiro profondo.En: The Vaporetto arrived slowly, and Luca boarded with a deep breath.It: Mentre il mezzo si muoveva, onde leggere facevano dondolare la barca.En: As the vessel moved, gentle waves made the boat sway.It: Il panorama di Venezia si allontanava, avvolto da una foschia invernale.En: The panorama of Venezia receded, shrouded in a winter mist.It: Alessandra gli mise una mano rassicurante sulla spalla.En: Alessandra placed a reassuring hand on his shoulder.It: "Non sei da solo, Luca."En: "You're not alone, Luca."It: Marco, l'ultimo del gruppo, osservava in silenzio.En: Marco, the last of the group, observed in silence.It: Sembrava sapere più di quanto dicesse.En: He seemed to know more than he was letting on.It: I suoi occhi scrutavano l'orizzonte, come se cercasse qualcosa nell'isola in lontananza.En: His eyes scanned the horizon, as if searching for something on the distant island.It: Poco dopo, il cielo si oscurò.En: Soon after, the sky darkened.It: Una tempesta improvvisa li colse di sorpresa.En: An unexpected storm caught them by surprise.It: Vento e onde facevano ballare il Vaporetto mentre Luca si teneva forte.En: Wind and waves made the Vaporetto dance while Luca held on tight.It: Poteva sentire il suo cuore accelerare.En: He could feel his heart racing.It: La paura cercava di avere la meglio su di lui, ma ricordò la sua missione.En: Fear tried to get the better of him, but he remembered his mission.It: "Siamo vicini," gridò Marco sopra il rumore del vento.En: "We're close," shouted Marco over the noise of the wind.It: C'era un'intonazione di certezza nella sua voce che Luca trovò sorprendentemente confortante.En: There was a tone of certainty in his voice that Luca found surprisingly comforting.It: Mentre il Vaporetto si avvicinava all'isola nascosta, le onde diventavano più calme, e l'entrata del laboratorio si avvicinava.En: As the Vaporetto approached the hidden island, the waves became calmer, and the entrance to the laboratory drew nearer.It: Luca si rese conto che Marco era dalla loro parte.En: Luca realized that Marco was on their side.It: Anche la tempesta sembrava ritirarsi, come se avesse fatto la sua parte nel superare le paure di Luca.En: Even the storm seemed to recede, as if it had played its part in overcoming Luca's fears.It: Giunti sulla terra ferma, l'enigma del laboratorio li attendeva.En: Once on dry land, the enigma of the laboratory awaited them.It: Il mistero si svelava un po' alla volta, portando con sé promesse di scoperte rivoluzionarie.En: The mystery unfolded little by little, bringing with it promises of revolutionary discoveries.It: Luca realizzò che aveva vinto contro la sua paura.En: Luca realized he had conquered his fear.It: Il viaggio in Vaporetto era stato un ostacolo superato, una prova del suo coraggio e della fiducia che poteva dare agli altri.En: The journey on the Vaporetto had been an obstacle overcome, a testament to his courage and the trust he could place in others.It: Marco non era solo un enigma, ma un alleato, mentre Alessandra restava la sua guida e amica fedele.En: Marco was not just an enigma but an ally, while Alessandra remained his guide and loyal friend.It: La nuova avventura nel laboratorio segreto di Venezia era solo l'inizio, ma era sicuro di una cosa: aveva il coraggio per affrontare qualsiasi sfida il futuro riservasse.En: The new adventure in the secret laboratory of Venezia was only the beginning, but he was sure of one thing: he had the courage to face any challenge the future might hold. Vocabulary Words:the biting cold: il freddo pungentethe calli (narrow streets): le callithe Vaporetto: il Vaporettothe canal: il canalethe laboratory: il laboratoriowrapped (tightly): strettothe tremor: il tremitothe vessel: il mezzoto sway: dondolarethe panorama: il panoramathe horizon: l'orizzontethe island: l'isolato darken: oscurarsithe storm: la tempestathe waves: le ondeto dance: ballareto shout: gridarethe certainty: la certezzathe entrance: l'entratacalm: calmothe enigma: l'enigmathe mystery: il misteroto unfold: svelarsipromise: promessarevolutionary: rivoluzionariethe courage: il coraggiothe trust: la fiduciathe obstacle: l'ostacolothe ally: l'alleatothe challenge: la sfida

David Jernigan 0:15Hello! Dr. Deb 0:16Hi there, sorry for all the confusion. David Jernigan 0:19Oh, no worries, you gotta love it, right? Dr. Deb 0:21Oh, I can’t hear you. David Jernigan 0:23No way, let’s see, my mic must be turned off? Dr. Deb 0:27Hang on, I think it’s me. Let’s see…Okay, let’s try now. David Jernigan 0:40Okay, can you hear me? Dr. Deb 0:42Yep, I can hear you now. David Jernigan 0:43Excellent, excellent. And, how are you today? Dr. Deb 0:48I am good, thank you. How about yourself? David Jernigan 0:50I’m good. Well, it’s good to finally meet you and get this thing rolling. Dr. Deb 0:56Yes, yes, I’m so sorry about that. David Jernigan 0:58That’s alright, that’s alright.So… Dr. Deb 1:01Yeah, go ahead. David Jernigan 1:03So, tell me about yourself before we get going. Dr. Deb 1:06Yeah, so I am a nurse practitioner. I’m also a naturopath. I have a practice here in Wisconsin. I’ve been treating Lyme for about 20 years, so I’m really excited to have this conversation and learn what you’re doing, because it’s so exciting and new. David Jernigan 1:21Well, thank you. Dr. Deb 1:22Yeah, so we treat a lot of chronic illness patients, do some anti-aging regenerative things as well, so… David Jernigan 1:30Yeah, I went to your website and saw you guys are killing it, looks like. Dr. Deb 1:35Yeah. David Jernigan 1:35Got a lot of good staff, it looks like. Dr. Deb 1:37Yeah, we’ve got great staff, great patients, busy practice. We have 5 practitioners, so we have about 15,000 patients in our practice right now. David Jernigan 1:46Well, excellent. Yeah. Excellent. Yeah, yeah.So, I’m excited for this discussion. Dr. Deb 1:53Good, me too. So I pre-recorded our intro, so we can just kind of dive right in, and I’ll just ask you to kind of introduce yourself a little bit, tell us a little bit about yourself, and, and then we can just dive right into it. David Jernigan 2:08All right. I’m Dr. David Jernigan, and I own the Biologic Center for Optimum Health in… Franklin, Tennessee, and I’ve been in practice for over 30 years. I shook Willie Bergdurfer’s hand, if anybody knows who that is. It’s kind of infamous now with some of the revelations that have happened about Lyme being a bioweapon and weaponized. But, you know, I’ve been doing this, probably longer than almost anybody that’s still in the business in the natural realm. It chose me. I did not choose Lyme. Matter of fact, there were many times in my career that I was like. You know, cancer’s easier because of the fact that everybody agrees, you know, what we’re dealing with. And in the 90s, it was a whole different reality, where nobody actually understood that you could have Lyme disease and not be coming from New England.You know, so I had actually the first documented case of a Lyme disease, CDC positive.Patient that had never left the state of Kansas before. So they couldn’t say that it wasn’t in Kansas, and so she had actually been, pregnant with… twin boys, and they were born CDC-positive as well, and so it is transmitted across the placenta we know.So, I, you know, the history of how I did all this was, in the 90s, probably 1996, probably, somewhere in there, 97. With this woman, you know, I… if you go into Robin’s pathology books from back then. Which we all used, medical doctors and everybody else studying. you know, there was basically a paragraph about Lyme disease, and on the national board tests, as you recall, it was probably like, what causes, or what is, bullseye rash associated with? And you’d had to guess Lyme disease, of course. Dr. Deb 4:07Female. David Jernigan 4:08But that was, you know, considered to be more a New England illness, and you would never see it anywhere else. But here was this woman. I knew… nothing about Lyme beyond what we had gotten taught in college, which was, like I say, next to nothing. And she would not let me stop feeding me information. I mean, you gotta remember, the internet wasn’t even hardly in existence in those years. I mean, it was brand new. It was supposed to be this information highway, and So I started purchasing, like a lot of doctors do even now, they start purchasing every kind of new supplement that’s supposed to work for bacteria. There was no product in those days that actually was Lyme-specific. I mean, nobody was really dealing with it naturally. It was always a pharmaceutical situation. Dr. Deb 5:04And a very short course at that. David Jernigan 5:06Yeah, 2 weeks of doxy and you’re cured, whether your symptoms are gone or not, which… she’d had the 2 weeks of doxy, and her symptoms and her son’s symptoms were not gone. And so, I absolutely just purchased everything I could find. Nothing would work. I mean, I could name names of products, and you would recognize them, because they’re still out there today. Dr. Deb 5:28Which is. David Jernigan 5:30Kind of a… A sad thing that natural medicine is still riding on these things that have the most marketing. Dr. Deb 5:37As opposed to sometimes the things that actually have the documented research. David Jernigan 5:42Behind it, and I am a doctor of chiropractic medicine, and I specialized all these years in chronic, incurable illnesses of all types. That may sound odd to a lot of people, but doctors of chiropractic medicine are trained just like a GP typically would be. The medical schools, as I understand it, got together, decades ago and said, wow, if all we did was… Crank out general practitioners for the next 10 years, we wouldn’t have still enough general practitioners to supply the demand. Dr. Deb 6:17Right. Everybody in medicine, in medical schools, wanted to be a specialist, because that’s where the money was, and it was… David Jernigan 6:24Easier, kind of, also, to… you know, just focus on one part of the body, and specialize in that. Dr. Deb 6:31Expert in that one area. David Jernigan 6:32So we all now have the same training. We all go through pre-med. We got a bachelor’s degree, I got my bachelor’s degree in nutrition, and through, Park University in Parkville, Missouri. And so, you know, when I ran out of options to purchase, I just used a technology that I developed, which was an advancement upon other technologies, but I called it bioresonance scanning. And I coined the term back in the 90s. It was a way to kind ofKind of like a sensitive test, you know, like you might. Dr. Deb 7:09I wouldn’t. David Jernigan 7:09Of applied kinesiology, then clinical kinesiology, then chiro plus kinesiology, then, you know, you can just keep going with all the advancements that were made. Well, this was an advancement upon those things, so… I developed… I was the first in… in… my known world of doctors to develop a way to detect adjunctively, obviously we can’t say it’s a primary diagnosis. Adjunctively detect the presence of a given specimen. So we could say, thus saith my test. It’s highly likely you have Borrelia burgdurferi. And, but I had to have the specimen on hand to be able to match what I call frequency matching to the specimen. Brand new concept in those days. And so I was able to detect whether or not my treatments were successful or not. This is something even now that’s really difficult for doctors, because antibody tests, even the most advanced ones, it’s still an antibody test. It’s still an immune response to an infection.And accurately, you know, some doctors will slam those tests, saying, well. That doesn’t mean you actually have the infection, that just means your body has seen it before, which is a correct statement, kind of. So being able to detect the presence, and even where in the body these infections are was a way huge advancement in the 90s, for sure it’s kind of funny, I think about a conference I went to, and cuz… I’m kind of jumping ahead. Because I ended up developing my own formula, just for this woman and her children, and it worked. And I was like, wow! Their symptoms were gone, all the blood tests came back negative. In those days, we were using the iGenX. Western blot, eventually. And the, what was called a Lyme urine antigen test. I don’t know if you remember that, because it… Only decades later did I meet, the owner of iGenX, Nick Harris. Dr. Deb 9:17Person. And I was like, whatever happened to the Luwat test? Because I took it off the market after a while. He said, honestly, we lost the antigen and couldn’t find it again. Oh, no. David Jernigan 9:27And so… but that was a brilliant test. It was the actual gold standard in those days. Again, the world… it can’t be understated how different the world was in the 90s. Dr. Deb 9:40Yeah. David Jernigan 9:41Towards natural medicine, even. Dr. Deb 9:44Oh, yeah. We think… we think it’s bad now, but, like, when I started, too, I started in the early 2000s, like, we were all hiding under the radar, like, you didn’t market, we would have never been on social media, we didn’t run ads, we didn’t do any. David Jernigan 10:00Right. Dr. Deb 10:01Because the medical boards were coming for us. David Jernigan 10:04Came after me. Dr. Deb 10:05Because I had the word Lime on my page, my website. David Jernigan 10:10You know, not saying that I treat Lyme. Dr. Deb 10:13Hmm? David Jernigan 10:13Yes Dr. Deb 10:15Just talking about mind. David Jernigan 10:16And it’s funny, because, once I had this formula, it was something… and I trained in Germany, in anthroposophical medicine, and they’ve been trained in herbal… making herbal extracts, making homeopathic remedies in the anthroposophical methodology, and I trained with the Hahnemann versions of homeopathy, which is just slightly different. Yeah. And, so I was well-versed with making some of my own formulas by that time. And so, it was really something that I wrote on the bottle, you know, and I had to call it something, so I called it Borreligin, which is still in existence, and it’s still a phenomenal herbal remedy right now. And to my knowledge, it’s the only frequency-matched herbal formula. Maybe still out there. Because unless you knew how to do my testing, the bioresonent scanning, there was no way to actually do frequency matching. Matter of fact, as a really famous herbalist attacked me online, saying, oh, none of these herbs will kill anything. And I’m like, that wasn’t what I was saying. I was saying, back in those days, I was saying, well, if… what would the body need to address these infections?You know, not, like, what’s gonna kill the infections for the body. Dr. Deb 11:38Right. David Jernigan 11:39Right? So it was a phenomenal way, but the LUAT test was amazing because what you’d do is you would give your treatment, like an MD would give an antibiotic for a week, ahead of time. Trying to increase the number of dead spirochetes showing up in your urine one day out of 3 days urine catch. So you’d wake up in the morning, you’d collect your urine 3 days in a row, and any one of those being positive is a positive. But it was a brilliant test because it wasn’t an antibody test. They were literally counting the number of dead pieces of Lyme bacteria in your urine. I mean, it was pretty irrefutable. So I had a grand slam on the… the Western blot on patients, and I’d also have a grand slam on the LUAT, and their medical doctors would say, oh, that doctor in the lab are probably in cahoots change some lab. Dr. Deb 12:38Of course. David Jernigan 12:39That come in. And I still see that today. You know, it’s like, oh my gosh, the better the tests are getting. There’s still a bias if you do your own research. Well, if you happen to be a doctor who loves research. And you’re a clinician, so you actually treat patients who’s gonna write the research study? Well, of course, the doctor who did the study, well, he’s biased, and I’m like, I still can’t influence lab tests. Well, lab tests aren’t everything. People scream over the internet at me. It’s like, well, a negative lab test doesn’t mean anything. I was like… I get that with the old Western blot testing. Dr. Deb 13:16Right. David Jernigan 13:16The more sensitive tests, which are very close to 100%, Sensitivity, and 100% specificity. So, meaning, like, they can… if you have the infection, they’re gonna find it. Dr. Deb 13:30They’ll find it, yeah. David Jernigan 13:31And if they… if you have the infection, they’re going to be able to tell you exactly 100% correctly what kind of infection it is. Back in those days, you couldn’t, you could just count the dead pieces, which was… Dr. Deb 13:43Yeah. David Jernigan 13:43Significant, but It’s funny, because when medicine does that, you know, mainstream medicine that’s backed by all the nice foundations who donate millions of dollars towards the research. Their negative tests are significant, but if you fund your own, Yours isn’t that significant. Dr. Deb 14:04Right, or what if we call something a seronegative autoimmune disease, like lupus or rheumatoid arthritis, because none of the tests are positive, but you have all the symptoms. Here, let me give you this $100,000 a year drug. David Jernigan 14:19Yeah. Dr. Deb 14:19And instead of looking for what might actually be causing the symptoms. That’s all okay, but what we do is not okay. David Jernigan 14:27Right. Yeah, it’s a double standard, and it’s getting better. I want to do… tell the world it is getting better. Some of the dinosaurs are retiring. Dr. Deb 14:36No. David Jernigan 14:37Way for people who are… Are more open-minded to new ideas. But, getting back to that woman, she… that formula that I made just for her and her son, I… She went online. Dr. Deb 14:54Which, I had never been on a news group. David Jernigan 14:58Not even sure I knew what one was, you know? Imagine, I’m kind of that dinosaur that… Cell phones were, like, these really big things with a big antenna sticking out of it, and… Dr. Deb 15:09Nope. David Jernigan 15:10So I thought I was pretty hot stuff, just that I actually had a computer software program that was running my front desk. And even then, it was an Apple IIe computer. Dr. Deb 15:21Right. David Jernigan 15:22Probably be pretty valuable right now if I’d kept it, but… Dr. Deb 15:25Mmm… David Jernigan 15:26It being an antique. But, suddenly people were calling my clinic, because the lady with the twin boys that was well was telling people on these research, I mean, these Lyme disease forums and boards online. And, I started going, oh my gosh, you know, as a doctor, it’s one thing to treat a person in your clinic, it’s a different thing to have your clinic name on the label. Like, we all do, Even now, and you’re supposed to write everything that’s on the label, and… all these guidelines, and I’m like, wow, I need to split this off. I mean, I def… I definitely want to help people, and this is… I was pretty excited about the results we were getting. Pre-treat… Pre-treatment and post-treatment. And, so… that’s where I developed, my nutraceutical business in the 90s called Journey Good Nutraceuticals. My advice to anybody thinking about doing the same thing, don’t put your last name on it. Dr. Deb 16:25– David Jernigan 16:25You know, because anytime negative anything comes out, there goes the Jernigan name, you know, the herbal, you know, there’s just all these, and especially nowadays, with all the bots that are just designed to slam natural medicine. Dr. Deb 16:38Yeah. David Jernigan 16:39And that is out there in a… and just ugly people. Dr. Deb 16:42Or should we just say, people with a different opinion? How’s that? David Jernigan 16:46Yeah. That are being less than supportive. Dr. Deb 16:49But. David Jernigan 16:51It was amazing, because by 1999, I presented my research, my first research, I’d never done research. This is what I would… I would say to a lot of people who go, my doctor did… I don’t know, my doctor doesn’t know what you’re doing, my doctor… I was like going, you know, most doctors don’t do research. They don’t publish anything. Their opinion is their opinion, but they don’t back it up in peer review, right? And so that’s what I always tried to do, was back it up in peer review and publish. And so, in 1999, I presented at the International Tick-Borne Diseases Conference in New York City. I’m telling you, it was like the country boy going to the city, you know, I got my… I got my suit on, and I looked all right, and my booth was wonderful, and all these different things, and it was just a big wake-up call.Because what we had demonstrated… let’s get back to the… and this was what I demonstrated with that first study. was that… A positive LUAC test, that Lyme urine antigen test for my Gen X, was a score of 32. Meaning, one of those 3 mornings urine had 32 pieces in the amount of urine they checked of deadline bacteria spirochetes. Okay? Okay. With antibiotic challenges, a highly positive was a score of 45. Dr. Deb 18:19Wow when I would give one dropper 3 times a day for a week. David Jernigan 18:24Ahead of time, and then do the person’s LUAT test, We were getting scores 100, 200… And at that point, we only had a couple, but we had a couple that were greater than 400. Yeah, dead pieces, where the lab just quits counting. They just said, somewhere over 400, right? Dr. Deb 18:45Yeah. David Jernigan 18:46Which, when the medical system at the conference, you know, I was the only natural doctor in the world that was… had any kind of proof of anything naturally that could outperform antibiotics. Can you imagine? Dr. Deb 18:59Yeah. And… David Jernigan 19:01They were just, oh my gosh, incredulous. They’re like, I’ve given the most… one guy came up to me, and to my face, and he goes, I’ve given the most aggressive antibiotic protocols And I’ve only seen one patient over 100. I was like, that makes this pretty significant, doesn’t it? But, it didn’t just, like, make us take off, because guess what? In Lyme world, if a pharmaceutical antibiotic made you feel horrible. That meant it was working. Dr. Deb 19:28That’s right. We used to, back in the day, if you didn’t herx. And had that horrible die-off reaction, for those of you who don’t know what a herx is, but if we didn’t make you herx, we weren’t doing our job right. David Jernigan 19:40You’re looking for your patients to feel horrible, and sometimes to the level of committing suicide. Dr. Deb 19:46Yes. David Jernigan 19:47So bad. Dr. Deb 19:48Yes. David Jernigan 19:49And I was the first doctor, I think, in the world to start screaming and hollering and saying, stop using the worsening of your patient’s symptoms as a guide to good treatment, because they’re… I wasn’t seeing it with my formulas. Because I was doing a comprehensive program of care. I think I was also one of the first doctors to say, we need to detoxify these people as we’re doing this. And you would sit there and say, well, sure you were. I was like, well, remember, there wasn’t a lot of communication. There wasn’t anybody on the internet saying, do this, do that. And, It was, it was interesting in those days. It was, how do you… How do you help the world heal from these things? That they don’t know they have. So later, I actually had a beautiful booth at a health… a big health expo in Texas, I remember, and I was like, you know, you spend a lot of money on the booth, and… Dr. Deb 20:43Yup. David Jernigan 20:43And you’re thinking about it because you’re funding the whole thing, you say, wow, if I only sell one case, I’ll at least cover my cost. Dr. Deb 20:51Yep. Yeah, you’re great. David Jernigan 20:52And I had this beautiful banner of, like, a blown-up tick’s mouth under microscope. You know those beautiful pictures of, like, all the barbs sticking out, and how they anchor themselves in your skin, and… And, thousand people walking by my booth, and they’re just like, keep walking, because they didn’t know they had Lyme. There was, like, and they had MS, maybe, but they don’t have Lyme, and so they just would keep walking. Nobody even knew. Why would I go to a conference in Texas? And I’m trying to say, no, guys, it’s everywhere. Dr. Deb 21:24Yeah. David Jernigan 21:24And… and everybody, you know, yes, you probably have this, you know, kind of thing. If you’re… if you… are chronically ill, almost, of any kind of way. You know, kind of trying to tell people this was… Again, in Robin’s pathology textbooks, one of the few things that it did tell you about Lyme was that it was called the Great… the New Great Imitator. Because it would imitate up to 200 or more different illnesses. So, it’s been an interesting journey, of… educating people, writing articles, but it was interesting, the lady who I first fixed, Laboratory verified, everything like that, symptoms went away, all that kind of fun stuff. Her children were fine, they’ve been fine for years now. When she went on the newsboards in the Lyme disease support groups, It created a war. Oh my goodness, it was like, how dare you? And, say that something natural might actually help, right? Dr. Deb 22:30Right, exactly. David Jernigan 22:32And, I even had… A… one of those first calls to… with a marketing company at one point, way a long time ago. And the lady got on the phone, the owner of the marketing company goes, I would have blood on my hands if I actually took your clinic on. Yeah, you can’t treat Lyme disease, and… Even the big, big associations that are out there are still largely that way. I mean, they’re getting better, but it’s just like… you know, a lot of the times, it’s herbs are good. Herbs will help. Good, you know, but they’re safe. So, it’s still a challenge to… to… present in mainstream Lyme communities, even. Because there’s this… Fear of doing anything outside of antibiotics. Dr. Deb 23:32Yeah, so let me ask you this. From your perspective. Why do you think so many chronic infections exist these days, like Lyme and the co-infections, Babesia, Bartonella, mold illness? And we talked a little bit about herbs and why they, antibiotics and things like that fail, but let’s talk a little bit about that. David Jernigan 23:53So, it’s fascinating. When I trained in Germany, they said that we, as humanity, has moved away from what they called the inflammatory diseases. You know, in the old days, it was. Lots of high fevers, purulent, pus-generating bacterial infections. And I said, as a society, we have… Dr. Deb 24:14Have shifted from those to what they call cold sclerotic diseases, which are your… David Jernigan 24:21Cancers, your diabetes, your atherosclerosis, your… and they said, we’re starting to see what used to only be geriatric diseases in our children. That’s how bad it’s gotten. We have suppressed fevers, we don’t… we don’t respect the wisdom of the human body. So, you know, the doctors say, step aside, body, I will fix this infection for you with this antibiotic. And so, what we’ve done with the, overuse of antibiotics, and this isn’t me just talking from a natural perspective, this is… Right, it’s everybody around the world is acknowledging. I’ll show you… I could show you a, a presentation, if we can do a screen-sharing situation. Yeah. About the antibiotic situation in the world, because it’s really concerning. But what I would say, and kind of like an advancement forward, is we are seeing mutated bacteria. You know, they talked about… do you remember when they found the Iceman, you know, the… You know, the prehistoric guy that’s… In the eyes, and he had Lyme bacteria. I was like, he had spirochetes, maybe. Dr. Deb 25:33Yeah. David Jernigan 25:33That isn’t a modified, mutated version. That’s just maybe the… Lyme… you know, Borrelia… call it Borrelia something, you know, it’s a spirochete, but what we’re dealing with today. Even under strep or staph, as you know, you know, Pseudomonas aeruginosa, you name it, whatever kind of infection a person has is not the same bacteria that your grandparents dealt with. Dr. Deb 26:01That’s right. David Jernigan 26:32It’s a much mutated, stronger, more resistant to treatment type of thing. So, I think that’s one reason. I think the, It’s great that we’re seeing, you know, Secretary Robert F. Kennedy Jr. bringing awareness to things that Like it or not, yeah, seed oils do create inflammation, and everyone in the natural realm, as you know. Has been trying to say this for probably how long? Dr. Deb 26:35Yeah, 25, 30 years. 20 years each. David Jernigan 26:48Yes. You know, thank goodness for people like Sally Fallon and her beautiful book, Nourishing Traditions, that started you know, Dr. Bernard Jensen’s books way back in the day, Dr. Christopher’s books way back in the day. Dr. Deb 26:48Damn. David Jernigan 26:49You know, all of them were way ahead of their time, saying, by the way, your margarine is only missing one ingredient from being axle grease. Dr. Deb 26:58Yeah. David Jernigan 26:58I think that was Dr. Jensen saying that at one point, probably 50, 60 years ago, I don’t know. Dr. Deb 27:03Yep. David Jernigan 27:04So, we’ve created this monster. We, we live in a very controlled environment, you know, of 72, 74 degrees at all times, we don’t sweat, we don’t have to work that hard, typically. You know, most of us aren’t out there like our ancestors were, so that’s making us more and more… Move towards the cold sclerotic diseases, of which even Lyme disease is, you know, which… Yes, it has inflammation, yes, but as a presentation, it’s very often associated with some of these Cold sclerotic diseases of mankind that we see now. Dr. Deb 27:46You have it. David Jernigan 27:47Yeah. Dr. Deb 27:48So, tell me, what is phage therapy? David Jernigan 27:52Well, may I show you a cool video? Dr. Deb 27:55Yeah, I’d love that. David Jernigan 27:56I did not make this video, this is just one of my favorites, because it’s from the National Institute of Health. Let’s see if I can just… Click the share screen thing. And get that to pop up. That’s not what I’m looking for, but it’s gonna be soon. Let’s go here… Alright, can you see that? Dr. Deb 28:18Yeah. David Jernigan 28:19Okay. Modern medicine faces a serious problem. Thanks in part to overuse and misuse of antibiotics, many bacteria are gaining resistance to our most common cures. Researchers are probing possible alternatives to antibiotics, including phages. So, bacteriophages, or we like to call them phages for short, are naturally occurring viruses that infect and kill bacteria. The basic structure consists of a head, a sheath, and tail fibers. The tail fibers are what mediate attachment to the bacterial cell. The DNA stored in the head will then travel down the sheath and be injected inside the cell. Once inside the cell, the phage will hijack the cellular machinery to make many copies of itself. Lastly, the newly assembled phages burst forth from the bacterium, which resets their phage life cycle and kills the bacterium in the process. Someday, healthcare providers may be able to treat MRSA and other stubborn bacterial infections using a mixture of phages, or a phage cocktail process would be first to identify what the pathogen is that’s causing the infection. So the bacterium is isolated and is characterized. And then there’s a need to select a phage in a process known as screening of phage that are either present in a repository or in a so-called phage library. That allows for many of the phages to be evaluated for effectiveness against that isolated I don’t know, bacterium. Phages were first discovered over 100 years ago by a French-Canadian named Felice Derrell. They initially gained popularity in Eastern Europe, however, Western countries largely abandoned phages in favor of antibiotics, which were better understood and easier to produce in large quantities. Now, with bacteria like these gaining resistance to antibiotics, phage research is gaining momentum in the United States once again. NIAID recently partnered with other government agencies to host a phage workshop, where researchers from NIH, FTA, the commercial sector, and academia gathered to discuss recent progress. NIH… So… That is… That is what phage therapy in… is. in what I call conventional phage. Let’s see, how do I get out of the share screen? Hope you already don’t see it. Dr. Deb 30:58Yep, at the top, there should just be a button. David Jernigan 31:00I don’t. Dr. Deb 31:00Stop sharing, yeah. David Jernigan 31:01So… Conventional phage therapy, as you just saw, is a lot like what it is that we’re doing, only the difference is they’re taking wild phages from the environment. They’re finding phages anywhere there’s, like, a lot of bacteria. And then they isolate those phages, and like he said, the gentleman at the very end said we put them in a library, and so there are banks of phages that they can actually now use, and One of the largest banks that I know of has about 700 different bacteriophages, or phages. In their bank that they can pull from. Dr. Deb 31:43Wow. Do you want to take a guess? David Jernigan 31:46How many bacteriophages they’ve identified are in the human gut, on average? Dr. Deb 31:52Oh my god, there’s gotta be more… David Jernigan 31:53Kinds, different kinds of phages, how many? Dr. Deb 31:56There’s gotta be millions. David Jernigan 31:57Well… In population, there’s… humongous numbers, numbers probably well beyond the trillions, okay? Hundreds of trillions, quadrillions, maybe, even. But in the gut, a recent peer-reviewed journal article said that there were 32,242 different types of bacteriophages that live naturally in your intestines, your gut. Dr. Deb 32:25Boom. David Jernigan 32:2632,000. Okay, so… If you read any article on phage therapy that’s in peer review, almost every single one in the very first paragraph, they use the same sentence. They go, Phages are ubiquitous in nature. They’re ubiquitous in nature. So my brain, when I find… when all this finally clicked together, and when we clicked together 5 years into my research, I could not get it to work for 5 years. I just kept going. But that sentence really got me going. I was, like, going, you know. If you look at what ubiquitous means, it says if Phages were the size of grains of sand. Like sand on the beach. They would completely cover the earth and be 50 miles deep. How crazy is that? Dr. Deb 33:24Wow. David Jernigan 33:25That’s how many phages are on the planet. There’s so many… they outnumber every species collectively on the planet. So, it’s an impossibility in my mind. I went, huh, it’s an impossibility that… You catching a, a sterile Bacteria, it’s almost an impossibility. Since the beginning of time, phages have been needing to use a reproductive host. And it’s very specific, so every kind of bacteria has its own kind of phage it uses as a reproductive host. Because phages are… and this is a clarification I want to make for people. just like in the old days, we were talking about the 90s, I talked to a veterinarian that had gotten in trouble with the veterinary board in her state. Dr. Deb 34:14Back in the old days. David Jernigan 34:16Because she gave dogs probiotics. And the board thought she was giving the dogs an infection so that she could treat them and make money off of the subsequent infection. Dr. Deb 34:28Oh my god. David Jernigan 34:29Nobody actually had heard of good, friendly bacteria in the veterinary world, I guess she said she had gotten in trouble, and she had to defend herself, that, no, I’m giving friendly, benevolent, beneficial bacteria. Okay, to these animals, and getting good results.So, phages… Are friendly, benevolent, beneficial viruses. That live in your body, but they only will infect a certain type of bacteria. So… What that means is if you have staff.Aureus, you know, Staphylococcus aureus bacteria. That bacteria has its own kind of phage that infects it called a staph aureus phage. E. coli has an E. coli phage. Each type of E. coli has its own phage, so Borrelia burgdurferi has its own Borrelia burgdurferi type of phage, whereas Borrelia miyamotoi alright? Or any of the other Borrelia species, or the Bartonella species, or the… you just keep going, and Moses has its own type of phage that only will infect that type of bacteria. So that’s… You know, when you realize, wow, why are we going to the environment Was my thought. Dr. Deb 35:54Yeah. David Jernigan 34:55Trying to find wild phages and put them into your body, and hopefully they go and do what you want them to do. What if we could trigger the phages themselves that live in your body to, instead of just farming that bacteria that it uses as a host, because what I mean by farming is the phages will only kill 40% of that population of bacteria a day. Dr. Deb 36:20Wow. David Jernigan 36:20And then they send out a signal to all the other phages saying, stop killing! Dr. Deb 36:24It’s like. David Jernigan 36:2560% of the bacteria population left to be breeding stock. It’s kind of like the farmer, the rancher, who… he doesn’t send his whole herd to the butcher. Dr. Deb 36:35Right. David Jernigan 36:36Just to, you know, he keeps his breeding stock. He sends the rest, right? So, the phages will kill 40% of the population every day, just in their reproduction process. Because once there’s so many, as you saw in the video, once the phage lands on top of the bacteria, injects its genetic material into the bacteria, that bacteria genetic engine starts cranking out up to 5,200 phages per bacteria. Dr. Deb 37:06I don’t know who counted all those… David Jernigan 37:08Inside of a bacteria, but some scientists peer-reviewed it and put it out there. that ruptures, and it literally looks like a grenade goes off inside of the bacteria. I wish I’d remembered to bring that video of a phage killing a bacteria, but it just goes, oof. And it’s just a cloud of dust. So, you’re breaking apart a lot of those different toxins and things. So… That’s… That was the impetus to me creating what I did. That and the fact that I looked it up, and I found out that phages will sometimes go… Crazy. I don’t know how to say it. Wiping out 100% of their host. And it could be a trigger, like change in the body’s pH levels, it could be electromagnetically done, you know, like, there’s been documentation of… I think it was, 50 Hz, electricity. Triggering one kind of phage to go… Crazy and annihilate its host population. There’s other ways, but I was, like, going, none of those fit me, you know? It’s not like I’m gonna shock somebody with a… Jumper cable or something to try to get phages to… to do that kind of thing. But the fact that it could be done, they can be triggered, they can switch and suddenly go crazy against their population. But what happens when they kill 100% of their host? The phages themselves die within 4 days. Dr. Deb 38:45Hmm. Because they can’t keep reproducing. David Jernigan 38:47There’s nothing to reproduce them, yeah. Dr. Deb 38:49Yeah. Especially… unless they’re a polyvalent phage, that means a phage that can segue and use. David Jernigan 38:54One or two other kinds of bacteria. To, as a reproductive host. But a lot of phages, if not the majority, are monovalent, which means they have one host that they like to use. And so… Borrelia, so… my study that I ended up doing, and I published the results in 2021, And it’s a small study, but it’s right in there at the high end, believe it or not, of phage research. Most phage research is less than 30 people. In the study. But, we did 26 people.And after one month of doing the phage induction that I invented, which only… Appears to only, induce or stimulate the types of phages that will do the job in your body. I don’t care what kind of phage it is. I don’t care if it’s a Borrelia phage, it may be a polyvalent phage that normally doesn’t use the Borrelia burgdurferi as its number one. Host, but it can. To go and kill that infection. And the fascinating thing is, there was a brand new test that came out at the same time I came out with the idea, literally the same weekend they presented. Dr. Deb 40:1511. David Jernigan 40:15ILADS conference in Boston in 2019. It was called the Felix Borrelia phage Test. So the Felix Borrelia phage test. Because Borrelia are often intracellular, right, they’re buried down in the tissue, they’re not often in the blood that much. And therefore, doing a blood test isn’t really that accurate. But you remember how there’s, like, potentially as many as 5,200 phages of that type erupt from each bacteria when it breaks apart. It’s way easier to detect those phages, because they’re now circulating, those 52, as you saw in the video. 5,200 different phages are now seeking out another Borrelia that they can infect. And so, while they’re out in circulation, that’s easy to find in the bloodstream. So, 77% of the people, so 20 out of 26, were tested after a 2-week period. After only a 4-day round of treatment. Because according to my testing, remember, I can actually test adjunctively to see if I can find any signatures for those kinds of bacteria. And I couldn’t after 4 days, so we discontinued treatment and waited Beyond the 4 days that would allow the phages themselves to die, so we waited about a week and a half.And redid the test. And 77%, so that 20 out of 26 of the people, were completely negative. Dr. Deb 41:50Wow. David Jernigan 41:52Which, you go, well, it’s just a blood test. Well, no, we actually had people that were getting better, like, they’d never gotten better before. We had one woman who was wheelchair-bound, and in two weeks was able to walk, and even ultimately wanted to work for my clinic. I’m just, like, going… Dr. Deb 42:07I didn’t want to write about all that. I wanted to write about the phages. I was like… David Jernigan 42:12article, I probably should have put some of those stories, because, Critics would say, well, you got rid of the infection, maybe, but… Did you fix the Lyme disease? Well, that’s… there’s two factors here that every doctor needs to understand. There’s the infection in chronic illness, there’s the infection, and then there’s the damage that’s been done. Because sometimes I have these people that would come in and say, well, Dr. Jernigan, it didn’t work for me, I’m still in the wheelchair. And I’m like, no, it worked. Repeat lab test over months says it’s gone, it’s gone, it’s gone. It’s like, we would follow, and 88% of the people we followed long-term were still negative, which is amazing to me. Dr. Deb 42:56And then they have to repair the damage. David Jernigan 42:59It’s the damages why you still have your symptoms. And that’s where the doctor has to get busy, right? Dr. Deb 43:06Right David Jernigan 43:06They were told erroneously by their doctor that originally treated them that they’d be well, they’d get out of the wheelchair, if he could actually kill all these infections. Dr. Deb 43:15It’s not true. David Jernigan 43:16Unless it’s caught early. So I love the analogy, and I’ve said it a thousand times.that Lyme disease and chronic infections are much like having termites in the wood of your house. If you find the termites early, then yeah, killing the infection, life goes back to normal, the storm comes and your house doesn’t fall down. But if it’s 20 years later. Killing the termites is still a grand idea. Right. But you have the damage in the wood that needs to be repaired as well. All the systems… when I talk about damage to the wood, I mean, like. All the bioregulatory aspects of the body, how it regulates itself, all the biochemical pathways, the metabolic pathways we all know about, getting the toxins that have been lodged in there for many years, stopping the inflammatory things that have been running crazy. Dealing with all those cytokines that are just running rampant through the body, creating this whole MCAS situation. Which are largely… Dr. Deb 44:21Coming from your body’s own immune cells called macrophages, which are not even… David Jernigan 44:26It’s not… a virus at all, it’s part of the immune system, it’s like a Pac-Man, and research shows that especially in spirochetes. There is no toxin. Now, I wrote 4 books. I think I wrote the very first book on the natural treatment of people with Lyme disease back in the 90s. Why did I write that? Not because I wanted to be famous, it’s a tiny book, actually, the first one was.I was just trying to help people get out of this idea that you will be well when you kill all the bugs. I was saying, it’s… you need to be doing this. If you can’t come to my clinic, at least do this. Try to find somebody that will do this for you. And that ultimately led to a bigger book.as I kept learning more, and I was like, going, well, okay, now at least do this amount of stuff. And you need to make sure your doctor is handling this, this, this, and this. And so, the third book was, like, 500 and something pages long. And then the fourth book was 500 and something pages long, and now they’re all obsolete with the whole phage thing, because this just rewrites everything. Dr. Deb 45:34Yeah. David Jernigan 45:34It’s pretty fascinating. Dr. Deb 45:37Do you think the war on bugs, mentality created more chronic illness than it solved? David Jernigan 45:44Because of the tools that doctors had to use, yes. We’re a minority, we’re still a minority, you and I. Dr. Deb 45:54Yep. Our doctoring… David Jernigan 45:56Methods I never had, and you’d never… maybe you did, but I’d never had the ability to grab a prescription pad and write out a prescription. I had to figure out, how do I get… and this was… and still my guiding thing, is like, how do I identify, number one, everything that can be found that’s gone wrong in the human body. And what do I need to provide that body? Like, the body is the carpenter. That has to do the repair, has to regenerate, has to do everything, has to get… everything fixed right? We can’t fix anything. If you have a paper cut, there isn’t a doctor on the planet that can make that go away. Dr. Deb 46:38Right. David Jernigan 46:39Of their own power, much less chronic illnesses. So, all the treatments are like the screws, saws, hammers, you know the carpenter must be able to use. So a lot of the time, doctors are just throwing an entire Home Depot on top of the carpenter. In the form of, like, bags of supplements, you know, hundreds of supplements, I’ve seen patients walk in my door with two suitcasefuls. And they were taking 70 bottles, 65 to 70 bottles of supplements, and I’d be just like, wow, your carpenter who’s been working for 24 hours a day, 7 days a week. He’s exhausted. There’s chaos everywhere, you don’t know where to. Dr. Deb 47:22Starting. David Jernigan 47:22He goes, you want me to do what with all this stuff? Dr. Deb 47:25Yep, I’ve seen the same thing. People… thousands, you know, several thousand dollars a month on supplements, and not any better. But they’re afraid to give up their supplements, too, because they don’t want to go backwards, either, and… there’s got to be a better way on both sides, the conventional side and the alternative side, although you and I don’t say it’s alternative, that’s the way medicine should be, but… David Jernigan 47:48Right. Dr. Deb 47:49We have to have a good balance on both sides. David Jernigan 47:52And I will say, too, in defense of doctors using a lot of supplements, I do use a lot of supplements. Dr. Deb 47:57Yeah, I do too. David Jernigan 47:58but I want to synergize what I’m giving the patient so that the carpenter isn’t overwhelmed and can actually get the job done. Like, everything has to work harmoniously together, so it’s not that… It’s not the number of supplements, and why would you need a lot of supplements? Well, because every system in your body is Messed up. My kind of clientele for 30 years. Our clientele, yours and mine. Dr. Deb 48:25Yeah. David Jernigan 48:26They have been sick, For decades, many of them. Dr. Deb 48:31Yeah. David Jernigan 48:31And if they went into a hospital, they honestly need every department. They need endocrinology, they need their kidney doctor, they need their… They’re a cardiologists, they need a neurologist, they need a rheumatologist. I mean, because none of those doctors are gonna deal with everything. They’re just gonna deal with one piece of the puzzle. And if they did get the benefit of all the different departments they need, yeah, they’d go out with a garbage bag full of stuff, too. Dr. Deb 48:57Hey, wood. David Jernigan 48:58Only, they’re not synergized. They don’t work together. You’re creating this chemistry set of who knows how much poison. And I want to tell your listeners, and I mean, you probably say this to your patients as well. There is a law of pharmacy that I learned eons ago, and it applies to natural medicine, too. Dr. Deb 49:21Yep. David Jernigan 49:22But the law says every drug’s primary side effect Is its primary action. So, if you listen to TV, you can see this on commercials. I love… I love listening to these commercials, because I’m like, wow. let’s… let’s… I don’t want to say I’ve named Brandon. I don’t know if that’s…Inappropriate to name a name brand, but let’s just say you have a pharmaceutical that is for sleep. After they show you this beautiful scene of the person restfully sleeping and everything like that, they tell you the truth. It’s like, this may cause sleepiness… I mean, sleeplessness. Dr. Deb 50:04Yeah. David Jernigan 50:04Found insomnia. Dr. Deb 50:06And headaches, and diarrhea. David Jernigan 50:08All the other things, and if it’s an antidepressant, what does the commercial do after it finishes showing you little bunny foo-foo, jumping through a green, happy people? They tell you, this may create depression, severe depression, and suicidal tendencies, which is the ultimate depression. So, I want everyone to understand you need to figure out what your doctor’s tools are that they’re asking you to take, and they’re wanting you to take it forever, generally in mainstream medicine, right? In the hospitals and everything. They don’t say, hey, your heart has this condition, take this medicine for 3 months, after which time you can get off. Dr. Deb 50:48Yep. David Jernigan 50:49not fixing it, right? So… That, on a timeline, there is a point, if it was truly even fixing anything. That you… it’s done what it should do, and you should get off, even if it’s a natural product. It’s just like. Dr. Deb 51:03Right David Jernigan 51:03It’s done what it should do, and you should get off, but instead. you go through the tree… the correction and out the other side, and that’s where it starts manifesting a lot of the same problems that it had. So, anti-inflammatories, painkillers, imagine the number one side effects are pain inflammation. So, the doctor says, well. If you say, hey, I’m having more pain, what does he do? He ups the dosage. And if he… if that doesn’t work, if you’re still in a lot of pain, which he would be, he changes it to a more powerful thing, right? But it starts the cycle all over again. So when you ask me, it’s like, why are we having so much chronic illness? It’s because of the whole philosophy. is the treatment philosophy of mainstream medicine that despises what you and I do. Because we’re… our philosophy from the start is the biggest thing. It’s like… We’re striving for cure. That dirty four-letter word, cure, we’re not even supposed to use it. And yet, if you look it up in Stedman’s Medical Dictionary, it just means a restoration of health. Remission. Everyone’s like, oh, I’m in remission. I’m like, remission is a drug term. It’s a medical term. Again, look it up in a medical dictionary. It is a pharmaceutical term for a temporary pause Or a reduction of your symptom, but because it’s just… symptom suppression, it will come back. It’s… remission is great, I suppose, in… At the end of, like, where you’ve exhausted everything, because I can’t fix everything, I don’t know about you. Dr. Deb 52:41No, I can’t either, yeah. David Jernigan 52:43you know, on my phone consults, I try to always remind people, as much as I get excited about my technologies gosh, I see so much opportunity to fix you. I always try to go, please understand, I’m gonna tell you what most doctors may not tell you on a phone consultation. I can’t fix everything. Dr. Deb 53:03Yeah. David Jernigan 53:03For all of my tricks, I can’t fix everything. Not tricks, but you know, all my technologies, and all my inventions. Phages, too. They are a tool. You know, antibiotics. I think I wrote a blog one time, it should be on my website somewhere, that says, Antibiotics do not… fix… neurological disease, or… I don’t know, something like that. You know, you’re using the wrong tool. I mean, it does what it does. Dr. Deb 53:32Yeah, you’re using a hammer to do what a screwdriver needs to. David Jernigan 53:35Yeah, you know, it’s like it’s… And yet, you can probably tell her… that you’ve had patients, too, that they go, Dr. Jernigan. My throat was so sore, and as soon as I swallowed that antibiotic. I felt better, and I’m, like, going… How long did it take? Oh, it was immediate! I was like, dude, the gel cap didn’t even have time to dissolve, I mean… Dr. Deb 53:58SIBO. David Jernigan 54:00But, it’s not going to repair the tissues that were all raw. kind of stuff. So, I mean, that ulceration of your throat that’s happening, the inflammation, there’s no anti-inflammatory effect of these things. So, I digress a little bit, but phages, too… I wrote an article that’s on the website, that’s setting healthy expectations for phages, because they want… we can see some amazing things happen, things that in my 30 years, I wish I had all my career to do over again, now having this tool. It’s just that much fun. I… when doctors around the country now are starting to use our inducent formulas, there’s, 13 of them now, formulas. For different broad-spectrum illness presentations. I tell them all the same thing, I was like, you are gonna have so much fun. Dr. Deb 54:53That’s exciting. Women. David Jernigan 54:54Winning is fun, you know? I was like. You know, mainstream medicine may never accept this, I don’t know. I feel a real huge burden, though, to do my best to follow a, very scientific methodology. I’ve published as much as I can publish at this time by myself. I never took money from the… the sources that are out there, because what do they do? They always come… money comes with strings. Dr. Deb 55:22Yes, it does. David Jernigan 55:23I don’t trust… I don’t trust… I mean, if you listen to the, roundtable that Our Secretary Robert F. Kennedy Jr. Dr. Deb 55:35Yeah. David Jernigan 55:36On Lyme disease last week the first couple of speakers were, like, pretty legit. I mean, all of them were legit, but I mean, they were, like, senators and congressmen or something like that, I think. And then you have… RFK Jr. himself, who’s legit. Yeah they were fessing up to the fact that, yes, they were suppressing anything to do with Lyme. Dr. Deb 56:00Yeah. David Jernigan 56:00Our… our highest levels of, marbled halls and pillars and… of medicine were doing everything the way I thought they were. They were suppressing me. I was like, how can you ignore the best formulas ever, and still, I think Borreligen, and now, induced native phage therapy are still, I believe, I don’t… I’ve never seen it, I could be wrong. The only natural things that have been documented in a medical methodology. Dr. Deb 56:34Hmm in the natural realm. I mean, all the herbs that we talk about. David Jernigan 56:39You know, there’s one that was really famous for a while, and it said, we gave… so many patients. This product, and other nutritional supplements. And at the end, X number of them were… dramatically better. That’s not research. Dr. Deb 56:57Right. That’s observation. David Jernigan 56:59The trick there was we gave this one thing, and then we gave high-dose proteolytic enzymes, we gave high dose this, we gave high dose that, but at the end of the study, we’re going to point back at the thing we’re trying to sell you as being what did it. Dr. Deb 57:12Which is what we do in all research, pretty much. David Jernigan 57:15Well… Dr. Deb 57:16tried to… David Jernigan 57:17Good guys, I hope. Dr. Deb 57:18Do the way we want, right? In… in conventional… David Jernigan 57:22Yeah. Dr. Deb 57:22Fantastic David Jernigan 57:23Very often, yeah, in conventional medicine, definitely. Yeah. And, it’s kind of scary, isn’t it, how many pharmaceuticals are slamming us with, because they’re… Dr. Deb 57:33Okay. David Jernigan 57:34There’s a new one on TV every day, and there’s. Dr. Deb 57:36Every day, yes. David Jernigan 57:37It’s like, who comes up with these names? They’re just horrible. Dr. Deb 57:40Yeah, you can’t pronounce them. David Jernigan 57:41I want to be a marketing company and come up with some Zimbabwehika, or something that actually they go with, and I’m like, I just made a million bucks coming up with it. I’ll be glad when that’s not on the TV anymore, which… Oh, me too. Me too. Dr. Deb 57:54Dr. Jaredgen, this was really wonderful. What do you want to leave our listeners with? David Jernigan 58:00Well, you know, everyone’s calling for a new treatment. Dr. Deb 58:05Yeah. You bet. David Jernigan 58:08I have done everything I can do to get it out there, scientifically, in peer review, so that if you want to look up my name. Dr. Deb 58:16I published an open access journal so that you didn’t have to buy the articles. Like, PubMed, you have to be a member. If you want to look at a lot of the research, you have to buy the articles. David Jernigan 58:26I’ve done everything open access so that people had access to the information. I honestly created induced native phage therapy to fix my own wife. I mean, I… I was… I used to think I could actually fix almost anything. Gave me enough time. And, I could not fix her. You know, the first 10 years, she was bedridden. Dr. Deb 58:49Wow. David Jernigan 58:50People go, oh, it’s easy for you, Dr. Jernigan, you’re a doctor. Dr. Deb 58:54Oh yeah, right? Yeah. David Jernigan 58:56Oh my gosh, how many tears have been shed, and how much heartache, and how much of this and that. I mean, 90% of our marriage, she was in, bed, just missing Christmas. All the horror stories you hear in the Lime world, that was her, and I could not get her completely well. And, she’s a very discerning woman. I say that in all my podcasts, because it’s. Dr. Deb 59:19Just… David Jernigan 59:16Amazing. It’s like, every husband, I think, should want a wife that’s… Always, right? Not that you surrender your own opinion, but it’s like, it’s… it was literally, I don’t know what, 6 months before the ILADS conference in Boston in 2029… in 2019 that She said, are you going to the ILADS conference this year? And I’m like, I’ve been going for, like, 15, 20 years, however long it’s been going on, and I was like, I’m not gonna go to this one. And, 3 days before the conference, she says, I think you should go. And I go, okay. Like I say, she’s generally right. And that… I bought a Scientific American magazine at the newsstand in the Nashville airport. Started reading a story about phages in that that copped that edition of the Scientific American, and It was a good article, but it wasn’t super meaty, you know. very deep on those, but I just was stimulated. Something about being at elevation. Dr. Deb 1:00:02Yeah. Your own mountains, I don’t know, I get all inspired. David Jernigan 1:00:25And I wrote in the margins and highlighted this and that until it was, like, ultimately, I spent the entire conference hammering this out. And it worked. And it’s been working, it’s just amazing. It’s… We’re over 200 different infections that we’ve… we’ve clinically or laboratory-wise documented. There’s a new test for my GenX called the CEPCR Lyme Panel. like, culture. 64 different types of infections, and I believe right now the latest count is something like 10 for 10 were completely negative. Dr. Deb 1:01:03Wow. David Jernigan 1:01:03These chronically infected people. And so, that hadn’t been published anywhere. So, in my published article, remember I was talking about that 20 out of the 26 were tested as negative for the infection? That doesn’t mean they’re cured, okay? Remember, they’re chronically damaged. That’s how we need to look at it. Dr. Deb 1:01:23funny David Jernigan 1:01:24damaged. You’re not just chronically infected. And, but with 30-day treatment.24 out of the 26 were tested as negative. Dr. Deb Muth 1:01:34That’s amazing. David Jernigan 1:01:35So 92% of the people were negative.Okay? The chances of that happening, when you run it through statistical analysis.The chances… when you compare the results to the sensitivity percentages, you know, the 100% specificity and 92% sensitivity of the…Of the lab testIt’s a 4.5 nonillion to 1 chance that it was a fluke. Isn’t that amazing? Now, nearly… I’m not even sure how many zeros that is, but it’s a lot. Dr. Deb Muth 1:02:08That’s is awesome. David Jernigan 1:02:09Like, if I just said, well, it’s a one in a million chance it was a fluke.Okay.So, lab tests don’t lie. You’re not done, necessarily, just because you got rid of the infections. Now that formula for Lyme has grown to be 90-plusmicrobes targeted in the one formula. So, we figured out we can actually target individually, but collectively, almost like an antibiotic that’s laser-guided to only go after the bad guys that we targeted.So, all the Borrelia types are targeted, all the Babesias, for,the Bartonellas, the anaplasmosis, you name it, mycoplasma types are all targeted in that one formula, because I said.Took my collective 30 years of experience and 15,000 patients.that I would typically see as co-infections and put them into that one formula, so…When we get these tests coming back that are testing for 64, it’s because of that.So, there’s a lot of coolnesses that I could actually keep going and going. Dr. Deb Muth 1:03:15That’s exciting. David Jernigan 1:03:15I love this topic, but I thank you for letting me come on. Dr. Deb Muth 1:03:18Thank you for joining us. How can people find you? David Jernigan 1:03:22Two ways. There’s the Phagen Corp company that is now manufacturing my formulas.That is P-H-A-G-E-N-C-O-R-P dot com. Practitioners can go there, and there’s a practitioner side of the website that’s very beefy with science, and… and all the formulas that were used, what’s inside of all the formulas, meaning what microbes are targeted by each one. Like, there’s a GI formula, there’s a UTI formula, there’s a SIRS formula, there’s a Lyme formula, there’s a central nervous system type infection formula, there’s… And we can keep going, you know, SIBO, SIFO formula, mold formula… I mean, we’ve discovered so many things that I could just keep going for hours, and… Dr. Deb Muth 1:04:05Yeah. David Jernigan 1:04:06About the discoveries, from where it started in its humble beginnings, To now, so… There’s another way, if you wanted to see our clinic website, is Biologics, with an X, so B-I-O-L-O-G-I-X, Center, C-E-N-T-E-R dot com. And, if somebody thinks they want to be a patient and experience this at our clinic, typically we don’t take just Easy stuff. All we see is chronic.Chronic cases from all over the world. Something like 96% of our patients come from other states and countries. And typically, I’ve been close to 90% for my whole career.About 30-something percent come from other countries in that, so… we’ve gotten really good and learned a lot in having to deal with what nobody else knows what to do with. But if you do want to do that, you can contact us. And, if you… If you don’t get the answers from my patient care staff, then I do free consultations. With the people that are thinking about, whether we can help them or not. Dr. Deb Muth 1:05:13Well, that’s excellent. For those of you who are driving or don’t have any way of writing things down, don’t worry about it, we’ve got you. We will have all of his contact information in our show notes, so you will be able to reach out to him. Thank you again for joining me. This has been an amazing conversation. David Jernigan 1:05:30Thank you, I appreciate you having me on. It was a lot of fun. The post Episode 252 – Induced Native Phage Therapy (INPT) & advanced natural therapies first appeared on Let's Talk Wellness Now.

Join Ivoclar (AND US!) this February at LMT Lab Day in Chicago. Ivoclar will be offering 16 different educational lectures over the three-day event, giving dental professionals plenty of opportunities to learn, connect, and grow. Visit labday.com/Ivoclar to view the full schedule and register, and be sure to stop by and see the Ivoclar team in the Windy City. Come see and talk to Elvis and Barb at all these amazing shows coming up in 2026 * Vision 21 in Las Vegas Jan 15-17 https://www.nadl.org/nadl-vision-21 * Cal-Lab Association Meeting in Chicago Feb 19-20 https://cal-lab.org/ * LMT Lab Day Chicago Feb 19-21 https://lmtmag.com/lmtlabday * Dental Lab Association of Texas Meeting in Dallas Apr 9-11 https://members.dlat.org/ * exocad Insights in Mallorca, Spain Apr 30 - May 1 https://exocad.com/insights-2026 This week we sit down with Stuart Steinbock for a wide-ranging conversation that blends dental industry history, innovation, and personal resilience. As a fourth-generation member of the Steinbock family, Stuart shares the origin story of Whip Mix (https://whipmix.com/)—from an egg beater with patented features to a global dental manufacturer—and his own unlikely path into the family business, including international expansion, lean manufacturing, and product development that helped shape how labs think about efficiency and quality The conversation follows Stuart's journey beyond Whip Mix into startups, direct-to-consumer aligners, 3D printing with Carbon (https://www.carbon3d.com/), pandemic-era manufacturing, and running a high-volume orthodontic lab, before landing at Digital Dental (https://www.digitaldental.com/) as president. Along the way, Stuart offers candid insights on entrepreneurship, digital workflows, ortho vs. restorative mindsets, leadership through change, and the human side of the dental industry—ending with a powerful personal update on family, recovery, and finding balance after adversity Special Guest: Stuart Steinbock.

In this episode, Dr. Theodore Schurr shares insights from his career researching genetic prehistories, linkages, and identities within transforming geopolitical landscapes of the past as well as contemporary sociopolitical shifts, including post-Soviet Russia and Georgia. Next, Dr. Schurr and hosts Cara and Chris reflect on the evolution of anthropology and genetic research, including breakthrough technologies and advanced field methods, changing bioethics, intentional relationships with communities, and exciting new approaches that are expanding our understanding of variation and genetic-environmental interactions of the past and present. Dr. Theodore (Tad) Schurr is a Professor in the Department of Anthropology and the Director of the Laboratory of Molecular Anthropology at the University of Pennsylvania. For over thirty years, he has investigated the genetic prehistory of Asia and the Americas through studies of mtDNA, Y-chromosome, and autosomal DNA variation in Asian, Siberian, and Native American populations. For these studies, his lab characterized genetic diversity in indigenous populations of Canada, the United States, Mexico, and the Caribbean. His research group is currently exploring the population history of Georgia (Caucasus), Pakistan, Kazakhstan, and Polynesia through collaborative studies in those regions. Other projects have investigated the role of the mtDNA in adaptation, cancer, complex diseases, and metabolism. ------------------------------ Find the papers discussed in this episode: Yardumian, A., Shengelia, R., Chitanava, D., Laliashvili, S., Bitadze, L., Laliashvili, I., ... & Schurr, T. G. (2017). Genetic diversity in Svaneti and its implications for the human settlement of the Highland Caucasus. American journal of physical anthropology, 164(4), 837-852. Schurr, T. G., Shengelia, R., Shamoon-Pour, M., Chitanava, D., Laliashvili, S., Laliashvili, I., ... & Yardumian, A. (2023). Genetic analysis of Mingrelians reveals long-term continuity of populations in Western Georgia (Caucasus). Genome Biology and Evolution, 15(11), evad198. Ancient Lineages: Reconstructing the Genetic History of Svaneti, Northwest Georgia https://www.penn.museum/sites/expedition/ancient-lineages/ ------------------------------ Contact Dr. Schurr: tgschurr@sas.upenn.edu ------------------------------ Contact the Sausage of Science Podcast and the Human Biology Association: Facebook: facebook.com/groups/humanbiologyassociation/, Website: humbio.org, Twitter: @HumBioAssoc Chris Lynn, Co-Host Website: cdlynn.people.ua.edu/, E-mail: cdlynn@ua.edu, Twitter:@Chris_Ly Cara Ocobock, Co-Host Website: sites.nd.edu/cara-ocobock/, Email:cocobock@nd.edu, Twitter:@CaraOcobock Mecca Howe, SoS Co-Producer, HBA Fellow LinkedIn: https://www.linkedin.com/in/mecca-howe/, Email: howemecca@gmail.com

Reagan Badger, Susan L Fink, Kathleen Hutchinson, Mark H Wener, Chihiro Morishima, Rebecca S Treger. Concurrent Anti-PR3 Immunoassay and cANCA Indirect Immunofluorescence Testing Provide Complementary Information for Clinical Laboratory Detection of Antineutrophil Cytoplasmic Antibodies. The Journal of Applied Laboratory Medicine, Volume 11, Issue 1, January 2026, Pages 83–97. https://doi.org/10.1093/jalm/jfaf168

Noel catches up with Eddie Deezen. The actor might be best known as Eugene in the Grease movies. Eddie voiced "Know-It-All" in the holiday classic, The Polar Express. He shares some great Tom Hanks stories. Eddie had roles in 1941, I Wanna Hold Your Hands and Wargames. His cult classics included Surf 2, Laserblast and Million Dollar Mystery. Eddie voiced "Mandark" in Dexter's Laboratory. He also had voice roles on SpongeBob Squarepants, Oswald, Darkwing Duck and Duckman.

What makes someone quit a six-figure advertising career to write books that help people think differently? In this episode of Legendary Leaders, host Cathleen O'Sullivan sits down with Karen Salmansohn—bestselling author, behavioral change expert, and the creative force behind NotSalmon.com—whose sharp wit and mortality-driven wisdom will make you rethink everything on your to-do list. Karen shares why fun isn't frivolous—it's fuel. She breaks down the science of why laughter literally shakes ideas loose, explains why her "e-pee-phanies" in the bathroom cracked more creative codes than caffeine ever did, and reveals the mortality marble jar that transformed how she spends every single month. With disarming honesty, she opens up about hiding her intelligence to be liked and finally "coming out" as a smart person in her sixties. Together, Cathleen and Karen explore the fatal flaw of to-do lists, why your identity is the puppet master of your habits, and how writing your own eulogy can wake you up from a "near-life experience." This conversation is for anyone who's tired of sleepwalking through their days and ready to design a life their future self will actually thank them for.   Episode Timeline: 00:05:36 How funny are you? Karen's son vs. Jon Stewart's verdict  00:06:34 Fun as a high-performance fuel (and meditation on steroids)  00:09:23 Manifestation, energy, and why confidence attracts results  00:14:48 From advertising to authorship: quitting the senior VP job her parents hated  00:19:38 The Häagen-Dazs theory on productivity: only pick what excites you  00:22:35 Procrastination strategies: turn your pain into purpose 00:27:03 Writing your eulogy: the wake-up call that changes everything  00:29:41 The fatal flaw of to-do lists (and why you need a to-die list)  00:33:31 The seven core values that minimize regret: A to G  00:38:31 Identity-based statements: "I am loving, so I find a way to Connecticut"  00:44:34 Feisty then, feisty now: how Karen sold the book her agent didn't want  00:46:33 Hiding her intelligence to be liked, then embracing it fully in her sixties 00:57:14 Hedonia vs. eudaimonia: why happiness isn't the goal  01:00:16 Life as a den of pleasure AND a laboratory for growth  01:12:51 Near-life experiences: when you're scrolling instead of living  01:16:07 The mortality marble jar: 437 marbles and a monthly reckoning   Key Takeaway: Your Identity Is the Puppet Master of Your Habits: Who you think you are determines what you actually do. If you walk around thinking "I'm sloppy," you'll do sloppy things. If you think "I'm a loving person," you'll find a way to get to Connecticut for your friend's birthday—even without a car. Studies show people who identified as "voters" were three times more likely to show up at the polls than those who just heard clever slogans. Change your identity statement, change your behavior.  To-Do Lists Prioritize Productivity, Not Meaning—That's Their Fatal Flaw: You can check off every box on your to-do list and still waste your life. Karen created a "to-die list" alongside her to-do list—a place for meaningful habits tied to core values, not just tasks. The top regrets of the dying? Working too hard, not spending time with friends, not allowing themselves to be happier, not living true to themselves. Your to-die list is the bridge between current you and the person your eulogy will describe.  Life Is a Den of Pleasure AND a Laboratory for Growth—You Need Both: We're addicted to instant gratification—scrolling, avoiding discomfort, waiting for "someday." But here's the truth: you can't seize every day. Aristotle said the goal isn't living pain-free; it's learning lessons that grow you into your best self. Emotional diversity is what makes you flourish. Instead of "seize the day," try "seize every other day." The moments in the laboratory of growth—where you get curious about your patterns and repair what keeps repeating—are what make the pleasure meaningful. The Mortality Marble Jar: Math That Shakes You Awake: Karen calculated how many months she has left if she lives to 100 (she promised her son). She bought that many marbles, put them in a jar, and every month she moves one marble to her "past" jar. The first time she did it, she couldn't remember what she'd done that month. Depressing. Now she intentionally plans meaningful experiences—dancing with friends, theater nights, time with her son—so when she holds that marble, she has something to report. The question that changes everything: "Is this really worth a marble of my life?"   About Karen Salmansohn: Karen Salmansohn is a bestselling author, behavioral change expert, and the founder of NotSalmon.com, where 1.5 million followers get their daily dose of psychology wrapped in wit. A former senior VP creative director who walked away from advertising in her twenties—despite her parents' protests—she's sold over 2 million books including How to Be Happy, Dammit and Think Happy, and her work has appeared everywhere from Oprah's platform to Psychology Today.Her latest book, Your To-Die-For Life, tackles mortality, regret, and the art of living intentionally—complete with a marble jar in her kitchen that tracks every month she has left if she lives to 100. Karen teaches that fun isn't a bonus, it's fuel, and that your identity is the puppet master of your habits.   Connect with Karen Salmansohn: Website (NotSalmon): https://www.notsalmon.com/  Book (Your To Die For Life): https://yourtodieforlife.com/  Instagram: https://www.instagram.com/notsalmon/  Twitter/X: https://x.com/Notsalmon  Facebook: https://www.facebook.com/Notsalmon/  YouTube: https://www.youtube.com/user/NotsalmonTV  Substack: https://notsalmon.substack.com/    Connect with Cathleen O'Sullivan:  Business: https://cathleenosullivan.com/  LinkedIn: https://www.linkedin.com/in/cathleen-osullivan/  Instagram: https://www.instagram.com/legendary_leaders_cathleenos/  YouTube: https://www.youtube.com/@LegendaryLeaderswithCathleenOS   FOLLOW LEGENDARY LEADERS ON APPLE, SPOTIFY OR WHEREVER YOU LISTEN TO YOUR PODCASTS.

This week, we dive deep into the evolving world of digital dentures with George Cowburn, along with denturist Robert MacLeay and digital designer Kaylee Jilbert. George shares his unconventional path from engineering into dentures, the early challenges of bringing CAD/CAM into removables, and why his company Perfit has evolved into Lab Pilot (https://www.labpilot.net/)—a cloud-based approach designed to meet labs and denturists where they are, not where software companies wish they'd be. Robert and Kaylee bring the real-world perspective, explaining how combining analog fundamentals with digital design unlocked predictable, better-fitting dentures and titanium partial frameworks that actually snap into place. From monolithic milled partials to same-day digital relines and cloud-based CAM without subscriptions, this conversation explores how “trad-digital” workflows could finally make digital dentures accessible, scalable, and practical for everyday labs—without sacrificing fit, function, or sanity. Happy Holidays from Ivoclar! As the year comes to a close, all of us at Ivoclar want to extend our heartfelt gratitude to the incredible Voices From the Bench community. Thank you for your partnership, your trust, and the support you've shown throughout the year. From our Ivoclar family to yours, we wish you a joyful, healthy, and safe holiday season. May your days be merry, your nights be bright, and your smiles shine like freshly fallen snow. Ho, ho, ho — Happy Holidays from Ivoclar! Big news is coming your way in the world of CAM. Our friends at Ivoclar have teamed up with FOLLOW-ME! Technology (https://www.follow-me-tech.com/) to bring the Ivotion Denture System (https://www.ivoclar.com/en_us/products/digital-processes/ivotion) into the HyperDent CAM (https://www.follow-me-tech.com/hyperdent/) workflow. That's right—your favorite pre-shaded, two-layer Ivotion discs, the ones that let you design and mill a complete denture in one seamless process with no bonding and no mess, are now moving beyond closed systems. Thanks to this new partnership, Ivotion can finally be milled on open machines through HyperDent. And it gets better: you'll first see this powerful workflow available on the Roland DWX-53 series mills (https://www.rolanddga.com/products/dental/dwx-53d)—already a staple in so many labs—as well as the Imagine iMills (https://www.imagineusa.com/legacy/s/mills/imill). If you've been waiting for a faster, cleaner, more flexible way to produce full dentures, this is it. Ivoclar and FOLLOW-ME! just made the future of denture manufacturing wide open. Get ready—HyperDent is about to change the way you mill Ivotion. Special Guests: George Cowburn, Kaylee Jilbert , and Robert MacLeay .

A recent Osteoporosis International review summarized multiple studies showing that microplastics have been detected in human bone tissue, where they disrupt bone cell activity, trigger inflammation, and weaken structural integrity Laboratory and animal studies show microplastics accelerate osteoclast activity and alter bone microarchitecture, linking environmental plastic exposure to rising rates of bone fragility and dysplasia Microplastics are not limited to bone; previous research has also detected them in the bloodstream, brain, placenta, heart, lungs, liver, kidneys, and reproductive tissues Ultrafine combustion particles (UFPs), which are smaller than microplastics, pose an even greater threat due to the vastly higher levels of exposure you face each day Lower your daily microplastic exposure by switching to natural fabrics, filtering your air and water, avoiding plastic containers, and replacing plastic kitchen tools with safer materials

Why were cats with GI disease rarely diagnosed 30 years ago? Let's talk feline Pancreatitis, EPI, and nutrition breakthroughs! Dr. Joerg Steiner explains why nutrition is foundational to internal medicine, how interdisciplinary science advances veterinary care, and why mentorship and training the next generation of scientists may be his most important legacy in this episode of Purr Podcast.Thanks for tuning in to the Purr Podcast with Dr. Susan and Dr. Jolle!If you enjoyed today's episode, don't forget to subscribe, rate, and leave us a review—it really helps other cat lovers and vet nerds find the show. Follow us on social media for behind-the-scenes stories, cat trivia, and the occasional bad pun. And remember: every day is better with cats, curiosity, and maybe just a little purring in the background. Until next time—stay curious, stay kind, and give your cats an extra chin scratch from us. The Purr Podcast – where feline medicine meets feline fun.

We're coming to you live from NOLA Lab Fest with two very different, but equally nerd-worthy conversations. A HUGE THANKS to Aidite North America (https://www.aidite.com/) that has made this all available. Go show them some serious love. First up, Elvis sits down with Rik Jacobs from Novenda Technologies (https://www.lake3d.com/) to talk about a truly disruptive production-scale 3D printer that can print multi-material and multi-color—at the same time. We dive into voxel-based printing, integrated hard/soft gradients, no supports, water-soluble wax, massive denture and night guard output, and why centralized production labs should be paying very close attention to what Novenda is building next. Then we switch gears and catch up with Jess Gray, whose career journey is a masterclass in saying “yes,” learning fast, and building something special. From front desk at Aspen to running a rapidly growing in-house lab in the Finger Lakes region, Jess walks us through analog-to-digital dentures, Exocad self-education, facial scanning for All-on-X, in-office workflows, team building, and what it really takes to scale a lab while still loving the bench. This episode is packed with inspiration, tech talk, and real-world lab ownership lessons you don't hear every day. Happy Holidays from Ivoclar! As the year comes to a close, all of us at Ivoclar want to extend our heartfelt gratitude to the incredible Voices From the Bench community. Thank you for your partnership, your trust, and the support you've shown throughout the year. From our Ivoclar family to yours, we wish you a joyful, healthy, and safe holiday season. May your days be merry, your nights be bright, and your smiles shine like freshly fallen snow. Ho, ho, ho — Happy Holidays from Ivoclar! Big news is coming your way in the world of CAM. Our friends at Ivoclar have teamed up with FOLLOW-ME! Technology (https://www.follow-me-tech.com/) to bring the Ivotion Denture System (https://www.ivoclar.com/en_us/products/digital-processes/ivotion) into the HyperDent CAM (https://www.follow-me-tech.com/hyperdent/) workflow. That's right—your favorite pre-shaded, two-layer Ivotion discs, the ones that let you design and mill a complete denture in one seamless process with no bonding and no mess, are now moving beyond closed systems. Thanks to this new partnership, Ivotion can finally be milled on open machines through HyperDent. And it gets better: you'll first see this powerful workflow available on the Roland DWX-53 series mills (https://www.rolanddga.com/products/dental/dwx-53d)—already a staple in so many labs—as well as the Imagine iMills (https://www.imagineusa.com/legacy/s/mills/imill). If you've been waiting for a faster, cleaner, more flexible way to produce full dentures, this is it. Ivoclar and FOLLOW-ME! just made the future of denture manufacturing wide open. Get ready—HyperDent is about to change the way you mill Ivotion. Special Guests: Jess Gray and Rik Jacobs.

The Awake Space Community Sponsors this podcast! If you want to watch the video with CC go to patreon.com/theawakespace - it's free to watchNew Members save up 50% on annual members for tiers at the $15 level and up. The $22 tier is being grandfathered as of Jan 1 - there's no change to existing members - other than they get first look at the new info and platform (we're leaving discord - yay) end of January. You can save 50% on annual membership at http://patreon.com/theawakespaceIN THE EPISODE Your host Laurie Rivers offers up the winning strategies to build with a forward focus as we head into 2026. She lets you in on where things are going with the Awake Space and her plans to help you build stability and sustainability next year and beyond. She also shares why astrology has been her laboratory and her framework is the applied results that has helped clients and students from around the world.Plus you get to find out what astrologers really can "see" in a chart during the Astrologers' RoundtableAnd Laurie gives you must know info about 2026 and how you can tackle it starting this week.Chapters00:00 Setting Intentions During Solstice Week03:05 Previewing 2026: Predictions and Preparation04:21 Astrology as a Tool for Growth and Healing04:47 Reflecting on the Year and Future Planning07:29 Shifting Perspectives: From Mundane to Uplifting10:10 The Quest for Understanding: Personal Journey and Insights13:00 The Power of Optimism and Inner Light15:52 Astrology as a Tool for Personal Growth18:43 Navigating Chaos: The Energy of 202621:04 Understanding Patterns: The Key to Growth27:27 Astrology as a Laboratory for Personal Transformation34:55 Thanks To Our Newest Members37:23 Astrologer's RoundTable55:57 Introduction to Astrology and Self-Knowledge57:23 2026 Predictions and Personal Energy59:55 Observing Energy and Managing Urgency01:03:05 Accountability and Planning for 202601:05:00 Setting Conditions for Expansion01:06:36 A Few Political Predictions for 2026

International Space Station leaders Laura Shaw and  Jennifer Buchli discuss the science, discoveries, and innovations that have defined nearly 25 years aboard the orbiting laboratory. HWHAP 406.

The Joint Readiness Training Center is pleased to present the one-hundredth-and-twentieth episode to air on ‘The Crucible - The JRTC Experience' and the fifth* annual Large Scale Combat Operations Symposium. Hosted by COL Ricky Taylor, the Commander of Ops Group (COG). Today's guests are all seasoned observer-coach-trainers (OCTs) from across Operations Group, LTC Amoreena “Ammo” York, MAJ David Pfaltzgraff, MAJ Marc Howle, MAJ Amy Beatty, MAJ Jeff Horn, CSM Frank Enriquez, SGM Matthew Bollinger, and MSG Lacey Remillard as well as CW3 Roy Sandoval from the US Army Special Operations Command's Special Operations Training Detachment. Opening remarks were provided by GEN David Hodnes (Available only live via Teams), the Commanding General of Transformation and Training Command (T2COM) and BG Jason Curl, the Commanding General of the Joint Readiness Training Center. Our panel members are observer-coach-trainers with numerous decisive action training environment rotations between them. LTC York is the Task Force Senior for the TF Aviation (CAB / ATF). MAJ Pfaltzgraff is the BDE S-3 Operations OCT and MAJ Howle is the Protection OCT for Brigade Command & Control (BDE HQ). MAJ Beatty is the Executive Officer OCT and MSG Remillard is the S-3 Operations Sergeant Major OCT for Task Force Sustainment (BSB/DSSB). MAJ Horn is the Executive Officer OCT for the Fires Support Task Force. CSM Enriquez is the Command Sergeant Major OCT for Live Fires Division. SGM Bollinger is the Senior Enlisted S-2 Intelligence Advisor for the Intelligence Warfighting Function. CW3 Sandoval is the Rotational Planner for USASOC's Special Operations Training Detachment.   The purpose of the ‘LSCO Symposium' is to advance conversation on warfighting and share observations and lessons learned. We will discuss large scale violence today, but this discussion transcends mission sets. Train for high end competition and scale down as required. This episode synthesizes JRTC trends and best practices for preparing units for their hardest days of ground combat in Large-Scale Combat Operations across multiple domains. A central theme is that continuous transformation must be anchored to disciplined fundamentals. Leaders repeatedly emphasize that emerging capabilities—UAS, ITN, AI-enabled targeting tools, precision fires, and advanced sustainment systems—amplify poor discipline as much as they amplify competence. Units struggle when they trade foundational skills for technology, compress training timelines, or assume proficiency in basics like MDMP rigor, rehearsals, reporting, security, and sustainment forecasting. The discussion reinforces that formations are not failing because of a lack of tools, but because of gaps in training management, insufficient repetitions at home station, and an erosion of shared doctrinal language that enables synchronization under stress.    The episode also highlights how LSCO success depends on integration across warfighting functions over time, not single moments of convergence. Best-performing units demonstrate disciplined commander–staff and commander–commander dialogue, deliberate risk articulation, and active NCO involvement throughout planning and execution. Persistent challenges include rushed or truncated MDMP, weak course-of-action analysis, fragmented IPO/SPO processes, and poor sustainment visibility that leads to overstocking, vulnerable cache sites, and exposed logistics nodes. Survivability on a transparent battlefield emerges as a recurring lesson: units must balance dispersion with functionality, manage electromagnetic signatures, rehearse degraded communications, protect sustainment forces, and treat rear areas as contested terrain. Taken together, the episode underscores a clear JRTC message—winning the first battles of LSCO requires disciplined fundamentals, rigorous planning, and relentless rehearsal long before units ever make contact.  If you'd like to read along, you can visit our LinkTree account and view either Scenesetter (https://tr.ee/P8GenLNFvW) or EXSUM (https://tr.ee/HPpEc3ckHP).   Part of S01 “The Leader's Laboratory” series.   Don't forget to checkout our first, second, third, and fourth annual Large Scale Combat Operations Symposium, episodes sixteen, thirty, sixty-six, and ninety-three of ‘The Crucible.'   For additional information and insights from this episode, please check-out our Instagram page @the_jrtc_crucible_podcast.   Be sure to follow us on social media to keep up with the latest warfighting TTPs learned through the crucible that is the Joint Readiness Training Center.   Follow us by going to: https://linktr.ee/jrtc and then selecting your preferred podcast format.   Again, we'd like to thank our guests for participating. Don't forget to like, subscribe, and review us wherever you listen or watch your podcasts — and be sure to stay tuned for more in the near future.   “The Crucible – The JRTC Experience” is a product of the Joint Readiness Training Center.   *The first annual LSCO Symposium was conducted at Ft. Benning/Moore but hosted by the JRTC Team.

The Joint Readiness Training Center is pleased to present the one-hundredth-and-nineteenth episode to air on ‘The Crucible - The JRTC Experience.' Hosted by COL Ricky Taylor, the Commander of Ops Group (COG). Today's guest is the Commanding General for the fabled 82nd Airborne Division, MG Brandon Tegtmeier, All American 06. The 82nd Airborne Division specializes in joint forcible entry operations via vertical envelopment, both airborne and air assault, into denied areas with a U.S. Department of Defense requirement to respond to crisis contingencies anywhere in the world within 18 hours. They have the Hollywood call-sign of “All American” Division and the motto of “In Air, On Land.”   This episode explores trends and best practices observed through the lens of an airborne division preparing for large-scale combat operations, with a consistent emphasis on fundamentals, training management, and condition setting at echelon. The discussion reinforces that success at division level is anchored in company-level and below proficiency, arguing that brigades and divisions can adapt rapidly during a CTC rotation, but deficiencies in small-unit fundamentals cannot be fixed once in contact. A recurring theme is the deliberate decompression of training—allowing platoons, companies, and battalions sufficient time to learn, rehearse, and apply lessons rather than rushing through compressed events. This approach enables leaders to internalize battle drills, reduce cognitive load under stress, and fight effectively in JRTC's “friction factory,” where units are tested under sustained pressure, casualties, logistics shortfalls, and enemy contact.    From an operational perspective, the episode highlights how airborne formations must think differently about setting conditions across the fight, integrating intelligence, fires, sustainment, protection, and deception over time rather than relying on single convergence moments. Key topics include commander-driven MDMP, disciplined risk dialogue between commanders and staffs, and the necessity of clearly articulating information requirements to higher headquarters when organic collection assets are limited. The conversation also addresses emerging best practices such as protecting long-range fires, using maneuver forces to enable deep effects, embracing deception and EMCON to survive on a transparent battlefield, and offloading risk to robotics and UAS through formations like the MFRC. Sustainment realities for light forces—especially water and ammunition management following airborne or austere insertions—are repeatedly emphasized as decisive factors. Taken together, the episode presents a clear message: airborne divisions win by mastering fundamentals, deliberately preparing leaders at every echelon, and synchronizing effects over time to preserve combat power and maintain momentum in LSCO.    Part of S01 “The Leader's Laboratory” series.   Don't forget to check-out XVIII Airborne Corps' social media pages, their handles are ‘82ndAirborneDivision' on Facebook, ‘82ndABNDiv' on X, and ‘82ndairbornediv' on Instagram.   For additional information and insights from this episode, please check-out our Instagram page @the_jrtc_crucible_podcast.   Be sure to follow us on social media to keep up with the latest warfighting TTPs learned through the crucible that is the Joint Readiness Training Center.   Follow us by going to: https://linktr.ee/jrtc and then selecting your preferred podcast format.   Again, we'd like to thank our guests for participating. Don't forget to like, subscribe, and review us wherever you listen or watch your podcasts — and be sure to stay tuned for more in the near future.   “The Crucible – The JRTC Experience” is a product of the Joint Readiness Training Center.

In 1965 Margaret Crane was a young designer creating packaging for a pharmaceutical company when a scientist gave her a tour of the lab. Looking at the long rows of pregnancy tests she thought, well anyone could do that test at home! So she set about designing a prototype for America's first home pregnancy test. While the design of the prototype was simple, convincing the company, the medical community and conservative social leaders that at-home pregnancy testing was safe and necessary was an uphill climb for Crane, who is only now receiving credit for her contributions to the industry. This show first aired in February 2024. Featuring: Margaret Crane - Graphic designer and inventor of the first home pregnancy test Wendy Kline - Dema G. Seelye Chair in the History of Medicine, History Faculty Purdue University Jesse Olszynko-Gryn - Head of the [Laboratory for Oral History and Experimental Media](https://www.mpiwg-berlin.mpg.de/research/projects/laboratory-oral-history-and-experimental-media) at Max Planck Institute for the History of Science  Arthur Kover - Emeritus Professor of Marketing, Fordham University Alexandra Lord - Chair, Division of Medicine and Science at the National Museum of American History Making Contact Staff: Host: Amy Gastelum Guest Producer: Anne Noyes Saini  Producers: Anita Johnson, Salima Hamirani, Amy Gastelum, and Lucy Kang Executive Director: Jina Chung Editor: Adwoa Gyimah-Brempong Engineer: Jeff Emtman  Digital Media Marketing: Lissa Deonorain Music:  Podington Bear, Rhythm and Strings  Learn More: National Museum of American History https://americanhistory.si.edu/collections/nmah_1803285 A Woman's Right to Know, Pregnancy Testing in 20th Century Britain - https://mitpress.mit.edu/9780262544399/a-womans-right-to-know/ Predictor, by Jennifer Blackmer https://newplayexchange.org/plays/348156/predictor Making Contact is an award-winning, nationally syndicated radio show and podcast featuring narrative storytelling and thought-provoking interviews. We cover the most urgent issues of our time and the people on the ground building a more just world.

Illnesses don't abide by borders. Laborastories host Dr. Paul J. Jannetto and Dr. Barbara Goldsmith, chair of the Association for Diagnostics & Laboratory Medicine's new Global Affairs Core Committee, discuss why it's imperative for laboratory medicine professionals to think globally and how the association is expanding its efforts to partner with and serve clinical laboratory communities around the world. With special guest: Dr. Barbara Goldsmith Hosted by: Dr. Paul J. Jannetto

A Special THANKS to Aidite North America for allowing the podcast to record at Nola LabFest. GO SHOW THEM SOME LOVE! aidite.com Duff Wilson's journey in dental technology is anything but typical. From getting thrown into high-volume removable work at a major lab in the early '90s to opening Wilson Dental Lab out of his home and building a lean, relationship-driven business, Duff's story is rooted in grit, loyalty, and doing things the right way—even when it's hard. Along the way, he shares how mentorship, state lab associations, and taking care of people shaped his career, including helping other technicians start their own labs and building a South Carolina–based milling center to support small labs. The conversation dives deep into the evolution of digital dentistry, zirconia, milling centers, design services, and why relationships—not products—are what truly matter in this industry. Duff explains how trust and support led him to work closely with Aidite (https://www.aidite.com/), why being lean is the key to longevity, and how redefining success after a life-changing health scare helped him create a sustainable lab, a better lifestyle, and a clear path for the next generation of technicians Happy Holidays from Ivoclar! As the year comes to a close, all of us at Ivoclar want to extend our heartfelt gratitude to the incredible Voices From the Bench community. Thank you for your partnership, your trust, and the support you've shown throughout the year. From our Ivoclar family to yours, we wish you a joyful, healthy, and safe holiday season. May your days be merry, your nights be bright, and your smiles shine like freshly fallen snow. Ho, ho, ho — Happy Holidays from Ivoclar! Big news is coming your way in the world of CAM. Our friends at Ivoclar have teamed up with FOLLOW-ME! Technology (https://www.follow-me-tech.com/) to bring the Ivotion Denture System (https://www.ivoclar.com/en_us/products/digital-processes/ivotion) into the HyperDent CAM (https://www.follow-me-tech.com/hyperdent/) workflow. That's right—your favorite pre-shaded, two-layer Ivotion discs, the ones that let you design and mill a complete denture in one seamless process with no bonding and no mess, are now moving beyond closed systems. Thanks to this new partnership, Ivotion can finally be milled on open machines through HyperDent. And it gets better: you'll first see this powerful workflow available on the Roland DWX-53 series mills (https://www.rolanddga.com/products/dental/dwx-53d)—already a staple in so many labs—as well as the Imagine iMills (https://www.imagineusa.com/legacy/s/mills/imill). If you've been waiting for a faster, cleaner, more flexible way to produce full dentures, this is it. Ivoclar and FOLLOW-ME! just made the future of denture manufacturing wide open. Get ready—HyperDent is about to change the way you mill Ivotion. Special Guest: Duff Wilson.

What if the expertise that makes your company valuable today could be replicated—or even surpassed—by AI within a year? If you're running or leading a business, you're already feeling the pressure: AI disruption is moving faster than your operating model can adapt. This episode helps you understand why the ground is shifting so quickly, what it means for the expertise inside your organization, and how you can stay ahead instead of getting blindsided by competitors who adopt AI more strategically and more rapidly. You'll walk away with clarity on: How AI is lowering the cost of expertise—and what that means for your competitive advantage. A practical way to rethink your business and operating model so you can adopt AI at an exponential pace, not a linear one. How to help your team embrace AI without fear by understanding new working modes like centaurs, cyborgs, and self-automators. Hit play now to learn the specific mindset and moves CEOs are using to turn AI disruption into a strategic edge. Check out: 06:45 — How Karim shifted from open-source innovation to AI This is where Karim explains the surprising path from crowdsourcing and NASA experiments to machine-learning breakthroughs—and why those early signals showed him AI would reshape business, not just technology. 22:10 — The big insight: AI is lowering the cost of expertise A must-hear moment. Karim explains why AI isn't just another tool—it fundamentally changes what expertise means within a company — and why CEOs need to view their business as a "bundle of expertise" being rewired. 36:55 — The three ways humans actually work with AI This section introduces centaurs, cyborgs, and self-automators—and what these modes reveal about adoption, resistance, identity, and where value will come from as AI accelerates. About Dr. Karim Lakhani Karim R. Lakhani is the Dorothy & Michael Hintze Professor of Business Administration at the Harvard Business School. He specializes in technology management, innovation, digital transformation and artificial intelligence (AI). His innovation-related research is centered around his role as the founder and co-director of the Laboratory for Innovation Science at Harvard and as the principal investigator of the NASA Tournament Laboratory. Karim is known for his original scholarship on open source communities and innovation contests and has pioneered the use of field experiments to help solve innovation-related challenges while simultaneously generating rigorous research in partnership with organizations like NASA, Harvard Medical School, The Broad Institute, TopCoder, The Linux Foundation and various private organizations. His digital transformation research investigates the role of analytics and artificial intelligence (AI) in reshaping business and operating models. This research is complemented through his leadership as co-founder and chair of the The Digital, Data, and Design (D^3) Institute at Harvard and as co-founder and co-chair of the Harvard Business Analytics Program, a university-wide online program transforming mid-career executives into data-savvy leaders.

The latest episode of the Georgia Tech Research Podcast focuses on a critical but often unseen component of Georgia's agricultural infrastructure: the Georgia Poultry Laboratory Network (GPLN). Host Stephanie Richter, a senior research scientist in GTRI's ATAS laboratory, is joined by Dr. Louise Dufour-Zavala, executive director of GPLN, for a conversation on poultry health, disease prevention, emergency response, and the laboratory network's close coordination with industry, state, and federal partners. Throughout the episode, Richter and Dufour-Zavala explore how GPLN functions day to day, why its work is essential to Georgia's economy, and how science, speed, and communication work together when animal health is on the line. GPLN exists to help keep Georgia's poultry flocks healthy, safe, and market-ready. That mission plays out through an extensive testing and surveillance operation, with approximately 1.7 million samples processed annually. The episode emphasizes that this testing supports not only flock health but also food safety, business continuity, and export eligibility.

Dr Annelise E. Barron Associate Professor of Bioengineering Dr Annelise E. Barron is the W.M. Keck Associate Professor of Bioengineering at Stanford University Education: Postdoc, UCSF/Chiron Corporation, Biomimetic & Bioorganic Chemistry (1997) Postdoc, Soane BioSciences/ACLARA Biosciences Inc., Molecular Biotechnology (1996) Ph.D., Univ. of California, Berkeley, Chemical Engineering (1995) B.S., Univ. of Washington, Seattle, Chemical Engineering (1990) Stanford Web page: https://med.stanford.edu/profiles/annelise-barron?tab=bio Laboratory web page: https://barronlab.stanford.edu/   Complete List of Published Works in MyBibliography: https://www.ncbi.nlm.nih.gov/myncbi/annelise.barron.1/bibliography/public/   Email: aebarron@stanford.edu   If you liked this and want to learn more go to my new website www.DrAnthonyChaffee.com

Biological resilience underpins healthy aging, and Anthony Molina, Ph.D., investigates how people resist, adapt to, and recover from age-related stressors. Molina defines three domains of resilience linked to aging and studies “life course” resilience using the Rancho Bernardo Study, a longitudinal cohort that starts in 1972 and tracks cognitive, sensory, physical function and comorbidities. His group analyzes trajectory scores from tasks such as the trail-making test and examines thousands of blood molecules to identify patterns that distinguish exceptionally resilient participants. Laboratory experiments show how age-related molecular profiles relate to mitochondrial function and ATP production. Molina's team also tests behavioral and nutritional interventions in rigorously designed clinical studies, combining molecular biomarkers of biological age with measures of physical performance, cognition, sensory abilities, and mental well-being. Series: "Stein Institute for Research on Aging" [Health and Medicine] [Show ID: 40958]

Biological resilience underpins healthy aging, and Anthony Molina, Ph.D., investigates how people resist, adapt to, and recover from age-related stressors. Molina defines three domains of resilience linked to aging and studies “life course” resilience using the Rancho Bernardo Study, a longitudinal cohort that starts in 1972 and tracks cognitive, sensory, physical function and comorbidities. His group analyzes trajectory scores from tasks such as the trail-making test and examines thousands of blood molecules to identify patterns that distinguish exceptionally resilient participants. Laboratory experiments show how age-related molecular profiles relate to mitochondrial function and ATP production. Molina's team also tests behavioral and nutritional interventions in rigorously designed clinical studies, combining molecular biomarkers of biological age with measures of physical performance, cognition, sensory abilities, and mental well-being. Series: "Stein Institute for Research on Aging" [Health and Medicine] [Show ID: 40958]

Biological resilience underpins healthy aging, and Anthony Molina, Ph.D., investigates how people resist, adapt to, and recover from age-related stressors. Molina defines three domains of resilience linked to aging and studies “life course” resilience using the Rancho Bernardo Study, a longitudinal cohort that starts in 1972 and tracks cognitive, sensory, physical function and comorbidities. His group analyzes trajectory scores from tasks such as the trail-making test and examines thousands of blood molecules to identify patterns that distinguish exceptionally resilient participants. Laboratory experiments show how age-related molecular profiles relate to mitochondrial function and ATP production. Molina's team also tests behavioral and nutritional interventions in rigorously designed clinical studies, combining molecular biomarkers of biological age with measures of physical performance, cognition, sensory abilities, and mental well-being. Series: "Stein Institute for Research on Aging" [Health and Medicine] [Show ID: 40958]

Biological resilience underpins healthy aging, and Anthony Molina, Ph.D., investigates how people resist, adapt to, and recover from age-related stressors. Molina defines three domains of resilience linked to aging and studies “life course” resilience using the Rancho Bernardo Study, a longitudinal cohort that starts in 1972 and tracks cognitive, sensory, physical function and comorbidities. His group analyzes trajectory scores from tasks such as the trail-making test and examines thousands of blood molecules to identify patterns that distinguish exceptionally resilient participants. Laboratory experiments show how age-related molecular profiles relate to mitochondrial function and ATP production. Molina's team also tests behavioral and nutritional interventions in rigorously designed clinical studies, combining molecular biomarkers of biological age with measures of physical performance, cognition, sensory abilities, and mental well-being. Series: "Stein Institute for Research on Aging" [Health and Medicine] [Show ID: 40958]

Episode Summary  Today's episode dives into a whirlwind of cosmic news, featuring a communications hiccup with NASA's MAVEN orbiter at Mars, the astonishing discovery of Earth's magnetic tail, and the unveiling of NASA's new Rover Operations Center. We also explore the intriguing hints of a methane-rich atmosphere on an exoplanet detected by the James Webb Space Telescope, a groundbreaking dual-mode drone from China, and Rocket Lab's innovative "Hungry Hippo" fairing design for their upcoming neutron rocket.### Timestamps & Stories  01:05 – **Story 1: MAVEN Orbiter Loses Contact with Earth****Key Facts**  - NASA's MAVEN orbiter has temporarily lost communication, crucial for relaying data from Mars rovers.  - The team is working to reestablish contact with the spacecraft.  03:15 – **Story 2: Earth Has a Magnetic Tail****Key Facts**  - A NASA study reveals Earth's magnetotail stretches 2 million kilometers into space, formed by solar wind interaction.  - Understanding this structure helps predict space weather impacts on technology.  05:00 – **Story 3: New Rover Operations Center at NASA****Key Facts**  - NASA opens the Rover Operations Center to support future lunar and Martian missions.  - The center integrates advanced AI and emphasizes partnerships with commercial space companies.  07:30 – **Story 4: James Webb Telescope's Potential Discovery****Key Facts**  - JWST observes the Trappist 1 system, hinting at a methane-rich atmosphere on Trappist 1 e.  - The findings are preliminary, and further observations are planned to clarify the signal.  09:10 – **Story 5: China's Dual-Mode Mars Drone****Key Facts**  - A new drone concept combines flying and rolling capabilities to enhance Mars exploration efficiency.  - The design aims to conserve energy while allowing exploration of hard-to-reach areas.  11:00 – **Story 6: Rocket Lab's Hungry Hippo Fairing****Key Facts**  - Rocket Lab's neutron rocket features a unique fairing design that opens like a “Hungry Hippo” to release payloads.  - This innovation streamlines the recovery process, contributing to rapid reusability in space launches.  ### Sources & Further Reading  1. NASA2. European Space Agency3. James Webb Space Telescope4. Rocket Lab5. Mars Exploration Program### Follow & Contact  X/Twitter: @AstroDailyPod  Instagram: @astrodailypod  Email: hello@astronomydaily.io  Website: astronomydaily.io  Clear skies and see you tomorrow!

Title: Evaluating the Reverse Slide Embedding Method vs. Heat Extractor Embedding in the Mohs Laboratory: A Comparative Quality Review of 100 Cases Authors: Tashsa Cromedy, Heather Frye, Ochsner MD Anderson Cancer Center, St. Tammany Cancer Center A Campus of Ochsner Medical Center Abstract:  Overview Accurate tissue embedding is critical in Mohs micrographic surgery for complete margin assessment. This study evaluates the efficacy of a reverse slide embedding method compared to the conventional heat extractor technique. The goal was to determine which method yields fewer artifacts or discrepancies that may compromise histologic interpretation and margin assessment. Methods A total of 100 Mohs cases were retrospectively reviewed in a controlled laboratory setting. Two embedding techniques were compared: Reverse Slide Method: 50 cases were embedded by placing the tissue on a chilled slide before embedding, ensuring orientation preservation and minimizing heat exposure. Heat Extractor Method: 50 cases were embedded using the traditional heat extractor to flatten and orient tissue in the embedding medium. All slides were reviewed by a Mohs surgeon for processing artifacts, orientation challenges, and histologic discrepancies. Validation The Mohs surgeon identified a total of 17 artifact inconsistencies or discrepancies across all cases: 13 instances were associated with the heat extractor method. 4 instances occurred with the reverse slide method. These findings suggest that the reverse slide method may reduce artifacts and improve embedding accuracy compared to the heat extractor, offering potential benefits for tissue integrity and diagnostic confidence in the Mohs laboratory. Conclusion The reverse slide embedding method demonstrated a significant reduction in embedding-related artifacts compared to the heat extractor technique. These findings support its use in the Mohs laboratory to enhance tissue quality, reduce the risk of diagnostic errors, and improve patient outcomes. Further studies with larger sample sizes and multi-lab validations are recommended to confirm these results.  

Laboratory managers face a critical choice between HEPA and carbon filtration systems. Understanding particle capture versus gas removal helps protect experiments, personnel, and compliance standards. To learn more, visit: https://www.finalfilters.com FinalFilters.com City: Spokane Address: 4008 East Broadway Avenue Website: https://www.finalfilters.com

This week we welcome back the dynamic duo of digital dentistry, Blake Roney and Patrick Dewey from S.I.N. 360 (https://sin360.us/) (Simplicity • Innovation • Nanotechnology) for a massive deep dive into implants, photogrammetry, and the ever-evolving world of full-arch workflows. Since their last visit in 2022, Blake has gone from new kid on the block to full-blown Exocad (https://exocad.com/) educator, and Patrick breaks down how S.I.N. has doubled down on innovation across implants, CAD/CAM, and photogrammetry. The guys walk us through the new Versalis implant line (https://sin360.us/versalis/), why one connection for all indications is a big deal for labs, and how S.I.N. is pushing efficiencies for high-volume, complex full-arch clinicians. Then comes the star of the show: the MicronMapper (https://sin360.us/micronmapper/)—a lighter, faster, more accurate photogrammetry system that doesn't just capture implants but verifies manufacturing accuracy, scans soft tissue, and reduces surgical guesswork. Blake breaks down real-world accuracy numbers, what RMSE actually means, why intraoral scanners aren't cutting it for full-arch, and how FitCheck is saving labs from misfires, wasted zirconia, and bad days. They also reveal the newest frontier: Tissue Mapper, a photogrammetry-based, scanner-free workflow that pulls bite, tissue, and implant data without fiducials or messy post-op scans. It's nerdy, innovative, and ridiculously cool for the high-volume teams ready to level up. If you love accuracy, numbers, full-arch workflows, or just really good dental tech nerding — this is your episode. Happy Holidays from Ivoclar! As the year comes to a close, all of us at Ivoclar want to extend our heartfelt gratitude to the incredible Voices From the Bench community. Thank you for your partnership, your trust, and the support you've shown throughout the year. From our Ivoclar family to yours, we wish you a joyful, healthy, and safe holiday season. May your days be merry, your nights be bright, and your smiles shine like freshly fallen snow. Ho, ho, ho — Happy Holidays from Ivoclar! Big news is coming your way in the world of CAM. Our friends at Ivoclar have teamed up with FOLLOW-ME! Technology (https://www.follow-me-tech.com/) to bring the Ivotion Denture System (https://www.ivoclar.com/en_us/products/digital-processes/ivotion) into the HyperDent CAM (https://www.follow-me-tech.com/hyperdent/) workflow. That's right—your favorite pre-shaded, two-layer Ivotion discs, the ones that let you design and mill a complete denture in one seamless process with no bonding and no mess, are now moving beyond closed systems. Thanks to this new partnership, Ivotion can finally be milled on open machines through HyperDent. And it gets better: you'll first see this powerful workflow available on the Roland DWX-53 series mills (https://www.rolanddga.com/products/dental/dwx-53d)—already a staple in so many labs—as well as the Imagine iMills (https://www.imagineusa.com/legacy/s/mills/imill). If you've been waiting for a faster, cleaner, more flexible way to produce full dentures, this is it. Ivoclar and FOLLOW-ME! just made the future of denture manufacturing wide open. Get ready—HyperDent is about to change the way you mill Ivotion. Year-end chaos is here. Labs are slammed, deadlines are brutal, and mistakes are not an option. That's when dental technicians rely on the one thing that never quits: https://www.rolanddga.com/applications/dental-cad-cam. The DWX-53DC (https://www.rolanddga.com/products/dental/dwx-53dc-5-axis-dry-dental-milling-with-automatic-disc-changer) is a true workhorse—24-hour automated milling that keeps your lab running, your overhead down, and your ROI up. No redos. No downtime. Just consistent, precise results. Built on decades of Japanese engineering, Roland delivers the reliability that keeps labs sane, profitable, and on schedule. Finish the year strong with the mill you can trust. Choose Roland DGSHAPE. Precision. Reliability. Performance. Learn more at rolanddga.com Special Guests: Blake Roney and Patrick Dewey.

Students from Denver's Manual High School take over the Radio 1190 airwaves on Dec. 5, 2025 to showcase their productions in collab with CU Boulder's Laboratory for Ritual Arts & Pedagogy (RAP LAB). Learn more at www.colorado.edu/lab/rap/

In spring 2023, journalist and filmmaker Antony Loewenstein published The Palestine Laboratory, a book tracing the way that Israeli military technology and weaponry, battle-tested on Palestinians, is exported around the world. Lowenstein argues that as Israel's surveillance and combat technologies are sold far and wide, we can expect to see the forms of violence carried out in Gaza, for example, appear elsewhere in the world. Last month, Jewish Currents published an article by Rhys Machold called “The Myth of Israeli Innovation,” which takes a critical look at what Machold has termed “the laboratory thesis” and examines how it obscures Israel's dependence on powerful allies, while doing PR for the overhyped Israeli tech sector. On this episode of On the Nose, Jewish Currents editor-in-chief Arielle Angel hosts Loewenstein and Machold for a comradely debate about the “laboratory thesis” and whether it serves a narrative of Zionist exceptionalism. The guests discuss how advanced Israeli weapons really are; how “Israeli” they are, given the role of Western governments and corporations in their development; and how much of Israel's “innovation” should be considered technological as opposed to political. They also explore whether or not Israel is on the verge of collapse, and how to characterize the balance of power between Israel and the US.Thanks to Jesse Brenneman for producing and to Nathan Salsburg for the use of his song “VIII (All That Were Calculated Have Passed).”Articles and Media Mentioned and Further ReadingThe Palestine Laboratory by Antony LoewensteinThe Palestine Laboratory, documentary series by Antony Loewenstein on Al Jazeera“The Myth of Israeli Innovation,” Rhys Machold, Jewish Currents“Reconsidering the laboratory thesis: Palestine/Israel and the geopolitics of representation,” Rhys Machold, Political Geography“How Palantir, Google & Amazon armed Israel's genocide in Gaza,” interview with Antony Loewenstein on The Big Picture, Middle East Eye “‘Lavender': The AI machine directing Israel's bombing spree in Gaza,” Yuval Abraham, +972 Magazine“Profiting from Terror in Cold War Latin America: Bishara Bahbah's Israel and Latin America: The Military Connection,” Alexander Aviña, Liberated Texts“From Domination to Extermination,” Shir Hever, Phenomenal World“

On this episode of SPOT Radio, Charlie Webb, CPPL, breaks down five common mistakes medical device manufacturers make around equipment purchase, maintenance, and calibration. These gaps create significant process risk and are frequent root causes of failed seals in sterile barrier systems.Charlie draws on 30 years of experience in medical device packaging to explain how improper procurement choices, inconsistent maintenance schedules, and inadequate calibration practices undermine seal integrity and increase the likelihood of product recalls and patient risk. He outlines practical steps to tighten controls, improve documentation, and design validation protocols that reduce failure modes.Listen in for clear, actionable guidance on preventing seal failures, streamlining validation, and protecting patients from exposure to non‑sterile devices. Whether you manage packaging engineering, quality, or regulatory affairs, Charlie's insights will help your organisation avoid costly mistakes and strengthen your sterile barrier strategy.About Charlie Webb CPPL: Charlie Webb CPPL is the founder and President of Van der Stahl Scientific, a medical device packaging and testing machine provider and packaging testing and calibration laboratories.He is also a certified internal auditor and is the Quality Manager for Van der Stähl Scientific's demanding ISO/IEC 17025 Laboratory accreditation. Under Charlie's quality management system, his lab received the MSI Continuous Improvement Award. Charlie is a member of the IOPP Medical Device Packaging Technical Committee. He is a former co-PM in the Kiip group and voting ASTM F02 technical committee and has multiple granted and pending patents on medical device packaging machinery and pouch testers.His current patent-pending technologies include a medical device tray sealer that will integrate pouch testing within the packaging machine to provide 100% real-time seal testing. Also, in development is his patented HTIP system (human tissue isolation pouch) this disposable system is designed to help avoid packaging machine contamination.Charlie Webb CPPL Email: Charlie@vanderstahl.comwebsite:  www.vanderstahl.com

Send us a textDid you know that someone needs blood in the United States every two seconds? Whether it's for surgeries, cancer treatment, traumatic injuries or something else, your blood donation could help save a life. Suzanne Felton, Laboratory manager at St. Luke's, and Adam Wilcox, St. Luke's Clinical Pharmacy manager and a frequent blood donor, join Dr. Arnold to discuss blood donation.If you are interested in donating blood, visit lifeservebloodcenter.org to schedule your donation appointment. Do you have a question about a trending medical topic? Ask Dr. Arnold! Submit your question and it may be answered by Dr. Arnold on the podcast! Submit your questions at: https://www.unitypoint.org/cedarrapids/submit-a-question-for-the-mailbag.aspxIf you have a topic you'd like Dr. Arnold to discuss with a guest on the podcast, shoot us an email at stlukescr@unitypoint.org.

The Catalonian Anti-Doping Laboratory was established in 1985, and this year marks their 40th anniversary of operations. Dr. Rosa Ventura Alemany is Director of the laboratory, which is within the Hospital del Mar Medical Research Institute (IMIM) in Barcelona, Spain. In this episode, she discusses how the laboratory and the field of anti-doping have evolved over the years, some of the lab's major contributions to anti-doping science, and current research projects spanning investigations of the use of sulfate metabolites as markers to detect anabolic steroids, glucocorticoids and how to differentiate between permitted versus prohibited administration, and the analysis of doping agents in dried blood spot (DBS) samples.

1/4. The Genesis of the Asteroid Hunter Mission and Early Rejections — Dante Lauretta — Lauretta, hired by mentor Mike Drake at the Lunar and Planetary Laboratory (LPL), initiated the asteroid sample return mission concept in 2004 following a pivotal meeting with Lockheed Martin's Steve Price. The team submitted its initial proposal to NASA in July 2004, which received the agency's lowest competitive ranking, designated Category 4. A subsequent refined mission proposal targeting asteroid 1999 RQ36 was formally rejected in December 2007 due to prohibitively high estimated costs relative to the NASA planetary science program budget allocation. 1930

This week, we sit down with Seth Smith, founder of the rapidly growing lab software company Greatlab.io (https://www.greatlab.io/), and Ryan Alexander from Vitality Dental Arts (https://www.vitalitydentalarts.com/), who's been living the GreatLab life since May and has plenty to say about it. Seth shares the long, winding road from e-commerce to dentistry, to clear aligners, to scanners, and finally to building what he hopes becomes the most modern, integrated, and speed-driven LMS in the industry. He talks workflow obsession, eliminating downloads, killing paper dockets, listening to lab pain points, and why he's visited over 100 labs (and keeps going). Ryan brings the real-world perspective from a 100-tech lab that went through multiple LMS transitions before landing on GreatLab. He explains how their booking teams shrank, inbound calls dropped by 50%, audits disappeared, and technicians suddenly found computers they “didn't have” once the system made their jobs easier. From the CRM that kills phone tag to ScanHub pulling every scanner into one feed, Ryan breaks down exactly what changed on the bench, in customer service, and across production. We also dig into bad scans (yes, 20% of them), doctor communication, automatic file routing, task automation, shipping integrations, data migration fears, and why some labs should not switch systems unless they're truly ready to modernize. If you've ever wondered what a cloud-based, automation-heavy, lab-built-from-the-ground-up LMS looks like—or why another lab described GreatLab as “a Ferrari while everyone else is a Civic”—this episode lays it all out. Learn more or request a demo: greatlab.io Find them in Vegas at NADL Visions (https://www.nadl.org/nadl-vision-21) and in Chicago at Lab Day (https://lmtmag.com/lmtlabday)! Happy Holidays from Ivoclar! As the year comes to a close, all of us at Ivoclar want to extend our heartfelt gratitude to the incredible Voices From the Bench community. Thank you for your partnership, your trust, and the support you've shown throughout the year. From our Ivoclar family to yours, we wish you a joyful, healthy, and safe holiday season. May your days be merry, your nights be bright, and your smiles shine like freshly fallen snow. Ho, ho, ho — Happy Holidays from Ivoclar! Elvis and Barb are gearing up for their chat with the HyperDent Dude himself, Jordan Greenberg from FOLLOW-ME! Technology (https://www.follow-me-tech.com/). At LabFest, Elvis found out that every hyperDENT (https://www.follow-me-tech.com/hyperdent/) license comes with Template Editor Lite — a built-in feature that lets you make safe, customized tweaks to your milling strategies. Whether you want to prioritize surface quality or speed, this tool gives you the control to fine-tune your results while FOLLOW-ME! keeps everything validated and reliable. Because in the end, us lab techs love to tinker — and hyperDENT makes it easy to choose your own CAM-venture. Special Guests: Ryan Alexander and Seth Smith.

Dr. Tamara Hancock, assistant teaching professor at Mizzou's College of Veterinary Medicine and 2025 Kemper Fellow, joins Brad's Bites to discuss the Veterinary Medicine Diagnostic Laboratory and its expansion.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

A study of more than 1.3 million Americans found that people living in areas with high trichloroethylene (TCE) levels had a 10% greater risk of Parkinson's disease than those in cleaner regions TCE, a solvent once used in dry cleaning and degreasing, persists in air, soil, and groundwater for decades, exposing people through contaminated water and indoor air — even far from industrial sites Laboratory research revealed that TCE damages dopamine-producing neurons, disrupts mitochondrial energy production, and causes toxic protein buildup like that seen in Parkinson's patients The studies show that chronic, low-level exposure to environmental toxins silently erodes brain health over time, especially in older adults with weakened cellular repair systems Reducing exposure through clean water, good ventilation, and low-toxin household choices — while supporting your cells through restorative sleep, regular movement, and whole, unprocessed foods — helps protect mitochondrial energy production and strengthen long-term neurological resilience

Disney is a common shared cultural experience. In this episode, Jill Peterfeso joins us to discuss how Disney's pixie dust can hook students and provide opportunities for critical examination in a variety of disciplines. Jill is the Eli Franklin Craven and Minnie Phipps Craven Professor of Religious Studies at Guilford College. She is the author of Womanpriest: Tradition and Transgression in the Contemporary Roman Catholic Church and a co-editor of Why the Magic Matters: Discovering Disney as a Laboratory for Learning. A transcript of this episode and show notes may be found at http://teaforteaching.com.

Join Elvis and Barb at all these amazing shows coming up in 2026 * Vision 21 in Las Vegas Jan 15-17 https://www.nadl.org/nadl-vision-21 * Cal-Lab Association Meeting in Chicago Feb 19-20 https://cal-lab.org/ * LMT Lab Day Chicago Feb 19-21 https://lmtmag.com/lmtlabday * Dental Lab Association of Texas Meeting in Dallas Apr 9-11 https://members.dlat.org/ * exocad Insights in Mallorca, Spain Apr 30 - May 1 https://exocad.com/insights-2026 This week, Barb and Elvis finally sit down for a long-overdue full episode with the man behind the Fans of Voices From the Bench Facebook group, second-generation lab owner, NADL (https://www.nadl.org/) President, and all-around industry cheerleader: Joe Young of Young Dental Laboratory (https://youngdentallab.com/). Joe shares his family's incredible journey from Hong Kong to Philadelphia, how his parents built a small ortho lab out of a spare room, and how he grew up trimming models on a step stool before eventually returning to the lab after college. He walks us through the evolution of the business—from analog ortho, to adding fixed, to diving head-first into early CAD/CAM. Today, Young Dental is a 26-tech, multi-department full-service lab serving PA, NJ, and DE. Joe talks about the challenges of ortho work in a digital world, the need for wire-bending talent, the rise of aligners, and the struggle of balancing old-school techniques with new-school tech. He also reflects on family legacy, his dad's 45 years as a CDT, and why keeping that generation's knowledge alive matters more than ever. As NADL President, Joe dives into board service, workforce development, collaboration across organizations, and his goal of connecting labs and vendors more effectively. Plus, he gives an honest look at what it's like to step into leadership, find your voice, and leave a legacy for the next wave of techs. Of course, it wouldn't be a VFTB episode without gifts, jokes, accidental innuendo, and a rapid-fire Q&A that reveals Barb's love of tomahawks and Elvis's dream of 88-degree weather. Happy Holidays from Ivoclar! As the year comes to a close, all of us at Ivoclar want to extend our heartfelt gratitude to the incredible Voices From the Bench community. Thank you for your partnership, your trust, and the support you've shown throughout the year. From our Ivoclar family to yours, we wish you a joyful, healthy, and safe holiday season. May your days be merry, your nights be bright, and your smiles shine like freshly fallen snow. Ho, ho, ho — Happy Holidays from Ivoclar! Elvis and Barb are gearing up for their chat with the HyperDent Dude himself, Jordan Greenberg from FOLLOW-ME! Technology (https://www.follow-me-tech.com/). At LabFest, Elvis found out that every hyperDENT (https://www.follow-me-tech.com/hyperdent/) license comes with Template Editor Lite — a built-in feature that lets you make safe, customized tweaks to your milling strategies. Whether you want to prioritize surface quality or speed, this tool gives you the control to fine-tune your results while FOLLOW-ME! keeps everything validated and reliable. Because in the end, us lab techs love to tinker — and hyperDENT makes it easy to choose your own CAM-venture. Special Guest: Joe Young.

Eugenia Mirica, PhD is the Laboratory Director of the Materials Science Laboratory at EMSL Analytical, Inc in Cinnaminson, NJ. Eugenia received her Ph.D. in Materials Science from Stevens Institute of Technology in 2002. She joined EMSL at the end of 2002 and she has been with the company ever since. Her expertise involves complex analyses employing a large variety of analytical techniques, utilized for the identification and the comprehensive characterization of various types of materials.

If you've heard the hammering of a woodpecker in the woods, you might have wondered how the birds can be so forceful. What does it take to whack your head against a tree repeatedly, hard enough to drill a hole? A team of researchers wondered that too and set out to investigate, by putting tiny muscle monitors on eight downy woodpeckers and recording them with high-speed video as they pecked away in the lab.Integrative organismal biologist Nick Antonson, co-author of a report on the work, joins Host Flora Lichtmen to peck away at the mystery.Plus, you can take two ant eggs with the exact same genes, and one can grow up to be a queen, the other a worker. Neuroscientist and evolutionary biologist Daniel Kronauer joins Flora to share recent research into how an ant becomes a queen.Guests: Dr. Nick Antonson is an NSF postdoctoral research fellow in the department of ecology, evolution, and organismal biology at Brown University.Dr. Daniel Kronauer is the Stanley S. and Sydney R. Shuman Professor in the Laboratory of Social Evolution and Behavior at The Rockefeller University in New York.Transcripts for each episode are available within 1-3 days at sciencefriday.com. Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.

Join Elvis and Barb at all these amazing shows coming up in 2026 * Vision 21 in Las Vegas Jan 15-17 https://www.nadl.org/nadl-vision-21 * Cal-Lab Association Meeting in Chicago Feb 19-20 https://cal-lab.org/ * LMT Lab Day Chicago Feb 19-21 https://lmtmag.com/lmtlabday * Dental Lab Association of Texas Meeting in Dallas Apr 9-11 https://members.dlat.org/ * exocad Insights in Mallorca, Spain Apr 30 - May 1 https://exocad.com/insights-2026 This week, we finally bring on a guest who has been six years in the making: the one and only Jordan Greenberg, the North America Managing Director of FOLLOW-ME! Technology (https://www.follow-me-tech.com/)—better known as the HyperDent (https://www.follow-me-tech.com/hyperdent/) guy. Jordan takes us on a wild ride through the world of CAM software, milling strategies, toolpaths, and the surprisingly fascinating story of how dental CAM even became what it is today. From his early days as a third-generation “dental nepo baby” to running a zirconia milling center with his dad, all the way to helping launch titanium-bar milling on Datron (https://www.datron.com/) D5 machines, Jordan's journey hits every corner of digital dentistry's evolution. He breaks down what CAM actually does in the simplest possible terms (yes, even Elvis-level simple), explains the magic behind toolpaths, tools, post-processors, and how HyperDent “drives the car” for hundreds of different mills. You'll hear how materials get validated, why some ideas labs come up with are physically impossible, and why you should ALWAYS talk to your CAM provider before releasing new materials or components into the world. Jordan also shares a behind-the-scenes look at solving problems like angulated screw channels, milling lithium disilicate pucks, and HyperDent's upcoming work on milled dentures—including Ivoclar's Ivotion processes coming to open CAM. Whether you mill every day or still think CAM is just “putting a crown in a puck,” Jordan demystifies it all with humor, honesty, and more tech insights than we've ever had on the podcast at once. * Dental Labs—The Ivoclar (https://www.ivoclar.com/en_us) Flash Sale Is On! * From November 3rd to 14th, Ivoclar is bringing you unbeatable deals on the equipment that will set your lab up for success in 2026. * Upgrade your mill, your furnace, or expand your workflow—and save big while doing it! * Plus, when you purchase a milling machine (https://www.ivoclar.com/en_us/products/product-list?page=1&limit=12&filters=%5B%7B%22id%22%3A%22professions%22%2C%22advancedFilter%22%3Afalse%2C%22values%22%3A%5B%22Lab%22%5D%7D%2C%7B%22id%22%3A%22categories%22%2C%22advancedFilter%22%3Afalse%2C%22value%22%3A%22Digital%20Equipment%22%7D%5D), you'll get delivery, installation, and training—all included. That means your lab will be production-ready from day one. * But hurry—these savings vanish after November 14th! * Contact your Ivoclar sales rep today and power up your lab for the year ahead. Elvis and Barb are gearing up for their chat with the HyperDent Dude himself, Jordan Greenberg from FOLLOW-ME! Technology (https://www.follow-me-tech.com/). At LabFest, Elvis found out that every hyperDENT (https://www.follow-me-tech.com/hyperdent/) license comes with Template Editor Lite — a built-in feature that lets you make safe, customized tweaks to your milling strategies. Whether you want to prioritize surface quality or speed, this tool gives you the control to fine-tune your results while FOLLOW-ME! keeps everything validated and reliable. Because in the end, us lab techs love to tinker — and hyperDENT makes it easy to choose your own CAM-venture. Year-end chaos is here. Labs are slammed, deadlines are brutal, and mistakes are not an option. That's when dental technicians rely on the one thing that never quits: https://www.rolanddga.com/applications/dental-cad-cam. The DWX-53DC (https://www.rolanddga.com/products/dental/dwx-53dc-5-axis-dry-dental-milling-with-automatic-disc-changer) is a true workhorse—24-hour automated milling that keeps your lab running, your overhead down, and your ROI up. No redos. No downtime. Just consistent, precise results. Built on decades of Japanese engineering, Roland delivers the reliability that keeps labs sane, profitable, and on schedule. Finish the year strong with the mill you can trust. Choose Roland DGSHAPE. Precision. Reliability. Performance. Learn more at rolanddga.com Special Guest: Jordan Greenberg.

Join Elvis and Barb at all these amazing shows coming up in 2026 * Vision 21 in Las Vegas Jan 15-17 https://www.nadl.org/nadl-vision-21 * Cal-Lab Association Meeting in Chicago Feb 19-20 https://cal-lab.org/ * LMT Lab Day Chicago Feb 19-21 https://lmtmag.com/lmtlabday * Dental Lab Association of Texas Meeting in Dallas Apr 9-11 https://members.dlat.org/ * exocad Insights in Mallorca, Spain Apr 30 - May 1 https://exocad.com/insights-2026 This week, we sit down with a guest whose journey hits all the right notes—literally! Meet Jonathan Bourke, a jazz guitarist turned dental technician who went from pouring models to designing full-arch restorations and running his own in-office lab. Jonathan shares how a chance gig driving for a denturist opened the door to a career he never expected, taking him from analog dentures to digital workflows, photogrammetry, and Exocad (https://exocad.com/) wizardry. Now a lab owner working directly with clinicians, Jonathan talks about collaboration in full-arch cases, teaching with Jensen Dental (https://jensendental.com/) and MiYO (https://miyoworld.com/), and what it's like to see his work come to life chairside. From learning CAM milling to demoing in front of dental rockstars, Jonathan's story is a reminder that artistry comes in many forms—sometimes from six strings, sometimes from six implants. * Dental Labs—The Ivoclar (https://www.ivoclar.com/en_us) Flash Sale Is On! * From November 3rd to 14th, Ivoclar is bringing you unbeatable deals on the equipment that will set your lab up for success in 2026. * Upgrade your mill, your furnace, or expand your workflow—and save big while doing it! * Plus, when you purchase a milling machine (https://www.ivoclar.com/en_us/products/product-list?page=1&limit=12&filters=%5B%7B%22id%22%3A%22professions%22%2C%22advancedFilter%22%3Afalse%2C%22values%22%3A%5B%22Lab%22%5D%7D%2C%7B%22id%22%3A%22categories%22%2C%22advancedFilter%22%3Afalse%2C%22value%22%3A%22Digital%20Equipment%22%7D%5D), you'll get delivery, installation, and training—all included. That means your lab will be production-ready from day one. * But hurry—these savings vanish after November 14th! * Contact your Ivoclar sales rep today and power up your lab for the year ahead. Elvis and Barb are gearing up for their chat with the HyperDent Dude himself, Jordan Greenberg from FOLLOW-ME! Technology (https://www.follow-me-tech.com/). At LabFest, Elvis found out that every hyperDENT (https://www.follow-me-tech.com/hyperdent/) license comes with Template Editor Lite — a built-in feature that lets you make safe, customized tweaks to your milling strategies. Whether you want to prioritize surface quality or speed, this tool gives you the control to fine-tune your results while FOLLOW-ME! keeps everything validated and reliable. Because in the end, us lab techs love to tinker — and hyperDENT makes it easy to choose your own CAM-venture. Special Guest: Jonathan Bourke.

“Gavin Newsom is slicker than Barack Obama or Zohran Mamdani. He lies without effort or shame,” Larry Elder warns. “The man is dangerous—and should not be underestimated.” In 2021, the former presidential candidate was infamously labeled “the black face of white supremacy” by the Erika D. Smith of the LA Times, in response to his rejection of the Democrat party, mocking of indoor mask-wearers, and citing crime statistics. “I believe that many policies that have been implemented by the left, often with the best of intentions, have a disproportionately negative effect on Black America,” Elder told Tavis Smiley in a radio interview. Larry Elder – known as the “Sage From South Central” is an American conservative political commentator, talk radio host, and former attorney. He hosts The Larry Elder Show, now on YouTube and the Salem Podcast Network. A former presidential candidate, he is the author of several books including As Goes California: My Mission to Rescue the Golden State and Save the Nation. Follow at https://x.com/larryelder Dr. Todd Rose is the co-founder and CEO of the think tank Populace and a former professor at the Harvard Graduate School of Education, where he founded the Laboratory for the Science of Individuality. He is the author of Collective Illusions and multiple other books. Follow at https://x.com/ltoddrose 「 SUPPORT OUR SPONSORS 」 Find out more about the brands that make this show possible and get special discounts on Dr. Drew's favorite products at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://drdrew.com/sponsors⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠  ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠• FATTY15 – The future of essential fatty acids is here! Strengthen your cells against age-related breakdown with Fatty15. Get 15% off a 90-day Starter Kit Subscription at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://drdrew.com/fatty15⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ • PALEOVALLEY - "Paleovalley has a wide variety of extraordinary products that are both healthful and delicious,” says Dr. Drew. "I am a huge fan of this brand and know you'll love it too!” Get 15% off your first order at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://drdrew.com/paleovalley⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ • VSHREDMD – Formulated by Dr. Drew: The Science of Cellular Health + World-Class Training Programs, Premium Content, and 1-1 Training with Certified V Shred Coaches! More at https://drdrew.com/vshredmd • THE WELLNESS COMPANY - Counteract harmful spike proteins with TWC's Signature Series Spike Support Formula containing nattokinase and selenium. Learn more about TWC's supplements at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://twc.health/drew⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ 「 MEDICAL NOTE 」 Portions of this program may examine countervailing views on important medical issues. Always consult your physician before making any decisions about your health. 「 ABOUT THE SHOW 」 Ask Dr. Drew is produced by Kaleb Nation (⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://kalebnation.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠) and Susan Pinsky (⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://twitter.com/firstladyoflov⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠e⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠). This show is for entertainment and/or informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment. Executive Producers • Kaleb Nation - ⁠⁠⁠https://kalebnation.com⁠⁠⁠ • Susan Pinsky - ⁠⁠⁠https://x.com/firstladyoflove⁠⁠⁠ Content Producer & Booking • Emily Barsh - ⁠⁠⁠https://x.com/emilytvproducer⁠⁠⁠ Hosted By • Dr. Drew Pinsky - ⁠⁠⁠https://x.com/drdrew⁠⁠⁠ Learn more about your ad choices. Visit megaphone.fm/adchoices

It's been another big year in AI. The AI race has accelerated to breakneck speed, with frontier labs pouring hundreds of billions into increasingly powerful models—each one smarter, faster, and more unpredictable than the last. We're starting to see disruptions in the workforce as human labor is replaced by agents. Millions of people, including vulnerable teenagers, are forming deep emotional bonds with chatbots—with tragic consequences. Meanwhile, tech leaders continue promising a utopian future, even as the race dynamics they've created make that outcome nearly impossible.It's enough to make anyone's head spin. In this year's Ask Us Anything, we try to make sense of it all.You sent us incredible questions, and we dove deep: Why do tech companies keep racing forward despite the harm? What are the real incentives driving AI development beyond just profit? How do we know AGI isn't already here, just hiding its capabilities? What does a good future with AI actually look like—and what steps do we take today to get there? Tristan and Aza explore these questions and more on this week's episode.Your Undivided Attention is produced by the Center for Humane Technology. Follow us on X: @HumaneTech_. You can find a full transcript, key takeaways, and much more on our Substack.RECOMMENDED MEDIAThe system card for Claude 4.5Our statement in support of the AI LEAD ActThe AI DilemmaTristan's TED talk on the narrow path to a good AI futureRECOMMENDED YUA EPISODESThe Man Who Predicted the Downfall of ThinkingHow OpenAI's ChatGPT Guided a Teen to His DeathMustafa Suleyman Says We Need to Contain AI. How Do We Do It?War is a Laboratory for AI with Paul ScharreNo One is Immune to AI Harms with Dr. Joy Buolamwini“Rogue AI” Used to be a Science Fiction Trope. Not Anymore.Correction: When this episode was recorded, Meta had just released the Vibes app the previous week. Now it's been out for about a month.  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.